CN114657078B - 一种高产大麻二酚酸的酿酒酵母菌株构建方法和应用 - Google Patents
一种高产大麻二酚酸的酿酒酵母菌株构建方法和应用 Download PDFInfo
- Publication number
- CN114657078B CN114657078B CN202210098008.0A CN202210098008A CN114657078B CN 114657078 B CN114657078 B CN 114657078B CN 202210098008 A CN202210098008 A CN 202210098008A CN 114657078 B CN114657078 B CN 114657078B
- Authority
- CN
- China
- Prior art keywords
- saccharomyces cerevisiae
- cannabidiol
- recombinant
- gene
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 98
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 title claims abstract description 98
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 title claims abstract description 51
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 title claims abstract description 51
- 229950011318 cannabidiol Drugs 0.000 title claims abstract description 51
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 title claims abstract description 51
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 title claims abstract description 51
- 238000010276 construction Methods 0.000 title abstract description 18
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 68
- 230000014509 gene expression Effects 0.000 claims abstract description 49
- 102100039556 Galectin-4 Human genes 0.000 claims abstract description 30
- 108010001515 Galectin 4 Proteins 0.000 claims abstract description 28
- 102000004190 Enzymes Human genes 0.000 claims abstract description 18
- 108090000790 Enzymes Proteins 0.000 claims abstract description 18
- 101100116572 Drosophila melanogaster Der-1 gene Proteins 0.000 claims abstract description 15
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 15
- 101100116570 Caenorhabditis elegans cup-2 gene Proteins 0.000 claims abstract description 14
- 101150005497 MRS2 gene Proteins 0.000 claims abstract description 14
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 8
- 101100351811 Caenorhabditis elegans pgal-1 gene Proteins 0.000 claims abstract description 6
- 239000012634 fragment Substances 0.000 claims description 65
- 230000002018 overexpression Effects 0.000 claims description 23
- 101100070241 Mus musculus Hcn2 gene Proteins 0.000 claims description 14
- 101100314583 Mus musculus Trim3 gene Proteins 0.000 claims description 14
- 238000012408 PCR amplification Methods 0.000 claims description 13
- 239000002773 nucleotide Substances 0.000 claims description 13
- 125000003729 nucleotide group Chemical group 0.000 claims description 13
- 101100243377 Mus musculus Pepd gene Proteins 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 230000004927 fusion Effects 0.000 claims description 9
- 230000037361 pathway Effects 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 claims description 7
- QXACEHWTBCFNSA-UHFFFAOYSA-N cannabigerol Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-UHFFFAOYSA-N 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 5
- 230000003213 activating effect Effects 0.000 claims description 4
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 3
- 238000003209 gene knockout Methods 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 238000003780 insertion Methods 0.000 claims description 3
- 230000037431 insertion Effects 0.000 claims description 3
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 abstract description 62
- 230000000694 effects Effects 0.000 abstract description 9
- 101100494726 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pep-4 gene Proteins 0.000 abstract description 8
- -1 prb1 Proteins 0.000 abstract description 8
- 101150108278 FMN1 gene Proteins 0.000 abstract description 4
- 230000001976 improved effect Effects 0.000 abstract description 3
- 108020001507 fusion proteins Proteins 0.000 abstract description 2
- 102000037865 fusion proteins Human genes 0.000 abstract description 2
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 101100166240 Cannabis sativa CBDAS gene Proteins 0.000 abstract 3
- WVOLTBSCXRRQFR-DLBZAZTESA-M cannabidiolate Chemical compound OC1=C(C([O-])=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-M 0.000 abstract 1
- SEEZIOZEUUMJME-FOWTUZBSSA-N cannabigerolic acid Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-FOWTUZBSSA-N 0.000 abstract 1
- SEEZIOZEUUMJME-UHFFFAOYSA-N cannabinerolic acid Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-UHFFFAOYSA-N 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 78
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 description 62
- 238000006243 chemical reaction Methods 0.000 description 19
- 230000001580 bacterial effect Effects 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- 239000007788 liquid Substances 0.000 description 17
- 229930003827 cannabinoid Natural products 0.000 description 16
- 239000003557 cannabinoid Substances 0.000 description 16
- 238000011144 upstream manufacturing Methods 0.000 description 16
- 108091005804 Peptidases Proteins 0.000 description 15
- 238000012163 sequencing technique Methods 0.000 description 15
- 229940065144 cannabinoids Drugs 0.000 description 13
- 239000004365 Protease Substances 0.000 description 12
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 11
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 11
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 11
- 239000005515 coenzyme Substances 0.000 description 11
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 11
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 11
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 11
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 11
- 239000005090 green fluorescent protein Substances 0.000 description 10
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 9
- 239000011768 flavin mononucleotide Substances 0.000 description 9
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 9
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 9
- 229940013640 flavin mononucleotide Drugs 0.000 description 8
- 108010021843 fluorescent protein 583 Proteins 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 238000009825 accumulation Methods 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 7
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 5
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 5
- 239000012190 activator Substances 0.000 description 5
- 108010017391 lysylvaline Proteins 0.000 description 5
- 101150009300 CBDAS gene Proteins 0.000 description 4
- 101150082479 GAL gene Proteins 0.000 description 4
- 101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 108010047857 aspartylglycine Proteins 0.000 description 4
- GVVPGTZRZFNKDS-JXMROGBWSA-N geranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-JXMROGBWSA-N 0.000 description 4
- 108010015792 glycyllysine Proteins 0.000 description 4
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 3
- POTCZYQVVNXUIG-BQBZGAKWSA-N Asp-Gly-Pro Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O POTCZYQVVNXUIG-BQBZGAKWSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000880493 Leptailurus serval Species 0.000 description 3
- LVTJJOJKDCVZGP-QWRGUYRKSA-N Leu-Lys-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O LVTJJOJKDCVZGP-QWRGUYRKSA-N 0.000 description 3
- RBEATVHTWHTHTJ-KKUMJFAQSA-N Lys-Leu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O RBEATVHTWHTHTJ-KKUMJFAQSA-N 0.000 description 3
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108010005233 alanylglutamic acid Proteins 0.000 description 3
- 108010092854 aspartyllysine Proteins 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 238000006114 decarboxylation reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 3
- 108010064235 lysylglycine Proteins 0.000 description 3
- 229910001425 magnesium ion Inorganic materials 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000002438 mitochondrial effect Effects 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108010061238 threonyl-glycine Proteins 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- 108010051110 tyrosyl-lysine Proteins 0.000 description 3
- XVZCXCTYGHPNEM-IHRRRGAJSA-N (2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O XVZCXCTYGHPNEM-IHRRRGAJSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 2
- KIUYPHAMDKDICO-WHFBIAKZSA-N Ala-Asp-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O KIUYPHAMDKDICO-WHFBIAKZSA-N 0.000 description 2
- GWFSQQNGMPGBEF-GHCJXIJMSA-N Ala-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N GWFSQQNGMPGBEF-GHCJXIJMSA-N 0.000 description 2
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 2
- KZXPVYVSHUJCEO-ULQDDVLXSA-N Arg-Phe-Lys Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=CC=C1 KZXPVYVSHUJCEO-ULQDDVLXSA-N 0.000 description 2
- HCAUEJAQCXVQQM-ACZMJKKPSA-N Asn-Glu-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HCAUEJAQCXVQQM-ACZMJKKPSA-N 0.000 description 2
- GWNMUVANAWDZTI-YUMQZZPRSA-N Asn-Gly-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N GWNMUVANAWDZTI-YUMQZZPRSA-N 0.000 description 2
- FTSAJSADJCMDHH-CIUDSAMLSA-N Asn-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N FTSAJSADJCMDHH-CIUDSAMLSA-N 0.000 description 2
- PDECQIHABNQRHN-GUBZILKMSA-N Asp-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O PDECQIHABNQRHN-GUBZILKMSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 102000004031 Carboxy-Lyases Human genes 0.000 description 2
- 108090000489 Carboxy-Lyases Proteins 0.000 description 2
- 241000006271 Discosoma sp. Species 0.000 description 2
- 230000008341 ER-associated protein catabolic process Effects 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 102100034545 FAD synthase region Human genes 0.000 description 2
- 108010038582 FMN phosphatase Proteins 0.000 description 2
- 102100028929 Formin-1 Human genes 0.000 description 2
- 101150103317 GAL80 gene Proteins 0.000 description 2
- 108010001498 Galectin 1 Proteins 0.000 description 2
- GVVPGTZRZFNKDS-YFHOEESVSA-N Geranyl diphosphate Natural products CC(C)=CCC\C(C)=C/COP(O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-YFHOEESVSA-N 0.000 description 2
- WLODHVXYKYHLJD-ACZMJKKPSA-N Gln-Asp-Ser Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N WLODHVXYKYHLJD-ACZMJKKPSA-N 0.000 description 2
- DSPQRJXOIXHOHK-WDSKDSINSA-N Glu-Asp-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O DSPQRJXOIXHOHK-WDSKDSINSA-N 0.000 description 2
- KKBWDNZXYLGJEY-UHFFFAOYSA-N Gly-Arg-Pro Natural products NCC(=O)NC(CCNC(=N)N)C(=O)N1CCCC1C(=O)O KKBWDNZXYLGJEY-UHFFFAOYSA-N 0.000 description 2
- SOEATRRYCIPEHA-BQBZGAKWSA-N Gly-Glu-Glu Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SOEATRRYCIPEHA-BQBZGAKWSA-N 0.000 description 2
- XTQFHTHIAKKCTM-YFKPBYRVSA-N Gly-Glu-Gly Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O XTQFHTHIAKKCTM-YFKPBYRVSA-N 0.000 description 2
- HFPVRZWORNJRRC-UWVGGRQHSA-N Gly-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN HFPVRZWORNJRRC-UWVGGRQHSA-N 0.000 description 2
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 2
- 101000848289 Homo sapiens FAD synthase region Proteins 0.000 description 2
- 101001059390 Homo sapiens Formin-1 Proteins 0.000 description 2
- MTFVYKQRLXYAQN-LAEOZQHASA-N Ile-Glu-Gly Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O MTFVYKQRLXYAQN-LAEOZQHASA-N 0.000 description 2
- 108091006671 Ion Transporter Proteins 0.000 description 2
- 102000037862 Ion Transporter Human genes 0.000 description 2
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 2
- RZXLZBIUTDQHJQ-SRVKXCTJSA-N Leu-Lys-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O RZXLZBIUTDQHJQ-SRVKXCTJSA-N 0.000 description 2
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 2
- SBANPBVRHYIMRR-GARJFASQSA-N Leu-Ser-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N SBANPBVRHYIMRR-GARJFASQSA-N 0.000 description 2
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 2
- YEIYAQQKADPIBJ-GARJFASQSA-N Lys-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)N)C(=O)O YEIYAQQKADPIBJ-GARJFASQSA-N 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- MHQXIBRPDKXDGZ-ZFWWWQNUSA-N Met-Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CNC(=O)[C@@H](N)CCSC)C(O)=O)=CNC2=C1 MHQXIBRPDKXDGZ-ZFWWWQNUSA-N 0.000 description 2
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 2
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- SCKXGHWQPPURGT-KKUMJFAQSA-N Phe-Lys-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O SCKXGHWQPPURGT-KKUMJFAQSA-N 0.000 description 2
- ABEFOXGAIIJDCL-SFJXLCSZSA-N Phe-Thr-Trp Chemical compound C([C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 ABEFOXGAIIJDCL-SFJXLCSZSA-N 0.000 description 2
- 229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 2
- ZUZINZIJHJFJRN-UBHSHLNASA-N Pro-Phe-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 ZUZINZIJHJFJRN-UBHSHLNASA-N 0.000 description 2
- FDMCIBSQRKFSTJ-RHYQMDGZSA-N Pro-Thr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O FDMCIBSQRKFSTJ-RHYQMDGZSA-N 0.000 description 2
- 101710091346 Transcriptional activator hac1 Proteins 0.000 description 2
- DVAAUUVLDFKTAQ-VHWLVUOQSA-N Trp-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N DVAAUUVLDFKTAQ-VHWLVUOQSA-N 0.000 description 2
- PKUJMYZNJMRHEZ-XIRDDKMYSA-N Trp-Glu-Arg Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PKUJMYZNJMRHEZ-XIRDDKMYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 2
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 2
- 108010020688 glycylhistidine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 108010034529 leucyl-lysine Proteins 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 108010009298 lysylglutamic acid Proteins 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 108010012581 phenylalanylglutamate Proteins 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108010031719 prolyl-serine Proteins 0.000 description 2
- 108010070643 prolylglutamic acid Proteins 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000003370 receptor cell Anatomy 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 108010048818 seryl-histidine Proteins 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 210000003956 transport vesicle Anatomy 0.000 description 2
- 108010084932 tryptophyl-proline Proteins 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- CWFMWBHMIMNZLN-NAKRPEOUSA-N (2s)-1-[(2s)-2-[[(2s,3s)-2-amino-3-methylpentanoyl]amino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CWFMWBHMIMNZLN-NAKRPEOUSA-N 0.000 description 1
- IAOXXKYIZHCAQJ-ACZMJKKPSA-N (2s)-2-[[2-[[(2s)-2-[[(2s)-2,4-diamino-4-oxobutanoyl]amino]propanoyl]amino]acetyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O IAOXXKYIZHCAQJ-ACZMJKKPSA-N 0.000 description 1
- IQSYWEWTWDEVNO-ZIAGYGMSSA-N (6ar,10ar)-1-hydroxy-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromene-2-carboxylic acid Chemical compound C([C@H]1C(C)(C)O2)CC(C)=C[C@H]1C1=C2C=C(CCC)C(C(O)=O)=C1O IQSYWEWTWDEVNO-ZIAGYGMSSA-N 0.000 description 1
- KJTLQQUUPVSXIM-ZCFIWIBFSA-M (R)-mevalonate Chemical compound OCC[C@](O)(C)CC([O-])=O KJTLQQUUPVSXIM-ZCFIWIBFSA-M 0.000 description 1
- CZXWOKHVLNYAHI-LSDHHAIUSA-N 2,4-dihydroxy-3-[(1r,6r)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-6-propylbenzoic acid Chemical compound OC1=C(C(O)=O)C(CCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 CZXWOKHVLNYAHI-LSDHHAIUSA-N 0.000 description 1
- DQPMXYDFWRYWQV-UHFFFAOYSA-N 2-[[6-amino-2-[[2-[(2-amino-3-methylbutanoyl)amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]acetic acid Chemical compound CC(C)C(N)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NCC(O)=O DQPMXYDFWRYWQV-UHFFFAOYSA-N 0.000 description 1
- 101150090724 3 gene Proteins 0.000 description 1
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 description 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 description 1
- 241000023308 Acca Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 1
- LSLIRHLIUDVNBN-CIUDSAMLSA-N Ala-Asp-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LSLIRHLIUDVNBN-CIUDSAMLSA-N 0.000 description 1
- SFNFGFDRYJKZKN-XQXXSGGOSA-N Ala-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)N)O SFNFGFDRYJKZKN-XQXXSGGOSA-N 0.000 description 1
- PAIHPOGPJVUFJY-WDSKDSINSA-N Ala-Glu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O PAIHPOGPJVUFJY-WDSKDSINSA-N 0.000 description 1
- CFPQUJZTLUQUTJ-HTFCKZLJSA-N Ala-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](C)N CFPQUJZTLUQUTJ-HTFCKZLJSA-N 0.000 description 1
- TZDNWXDLYFIFPT-BJDJZHNGSA-N Ala-Ile-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O TZDNWXDLYFIFPT-BJDJZHNGSA-N 0.000 description 1
- AWZKCUCQJNTBAD-SRVKXCTJSA-N Ala-Leu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN AWZKCUCQJNTBAD-SRVKXCTJSA-N 0.000 description 1
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 1
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 1
- DEWWPUNXRNGMQN-LPEHRKFASA-N Ala-Met-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@@H]1C(=O)O)N DEWWPUNXRNGMQN-LPEHRKFASA-N 0.000 description 1
- BTRULDJUUVGRNE-DCAQKATOSA-N Ala-Pro-Lys Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O BTRULDJUUVGRNE-DCAQKATOSA-N 0.000 description 1
- AOAKQKVICDWCLB-UWJYBYFXSA-N Ala-Tyr-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N AOAKQKVICDWCLB-UWJYBYFXSA-N 0.000 description 1
- ZXKNLCPUNZPFGY-LEWSCRJBSA-N Ala-Tyr-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N ZXKNLCPUNZPFGY-LEWSCRJBSA-N 0.000 description 1
- IYKVSFNGSWTTNZ-GUBZILKMSA-N Ala-Val-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IYKVSFNGSWTTNZ-GUBZILKMSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- VKKYFICVTYKFIO-CIUDSAMLSA-N Arg-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N VKKYFICVTYKFIO-CIUDSAMLSA-N 0.000 description 1
- YFBGNGASPGRWEM-DCAQKATOSA-N Arg-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YFBGNGASPGRWEM-DCAQKATOSA-N 0.000 description 1
- RFXXUWGNVRJTNQ-QXEWZRGKSA-N Arg-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N RFXXUWGNVRJTNQ-QXEWZRGKSA-N 0.000 description 1
- KRQSPVKUISQQFS-FJXKBIBVSA-N Arg-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N KRQSPVKUISQQFS-FJXKBIBVSA-N 0.000 description 1
- UBCPNBUIQNMDNH-NAKRPEOUSA-N Arg-Ile-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O UBCPNBUIQNMDNH-NAKRPEOUSA-N 0.000 description 1
- AGVNTAUPLWIQEN-ZPFDUUQYSA-N Arg-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N AGVNTAUPLWIQEN-ZPFDUUQYSA-N 0.000 description 1
- VIINVRPKMUZYOI-DCAQKATOSA-N Arg-Met-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O VIINVRPKMUZYOI-DCAQKATOSA-N 0.000 description 1
- OWSMKCJUBAPHED-JYJNAYRXSA-N Arg-Pro-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OWSMKCJUBAPHED-JYJNAYRXSA-N 0.000 description 1
- PDQBXRSOSCTGKY-ACZMJKKPSA-N Asn-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N PDQBXRSOSCTGKY-ACZMJKKPSA-N 0.000 description 1
- OLGCWMNDJTWQAG-GUBZILKMSA-N Asn-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(N)=O OLGCWMNDJTWQAG-GUBZILKMSA-N 0.000 description 1
- IICZCLFBILYRCU-WHFBIAKZSA-N Asn-Gly-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IICZCLFBILYRCU-WHFBIAKZSA-N 0.000 description 1
- OPEPUCYIGFEGSW-WDSKDSINSA-N Asn-Gly-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OPEPUCYIGFEGSW-WDSKDSINSA-N 0.000 description 1
- GJFYPBDMUGGLFR-NKWVEPMBSA-N Asn-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CC(=O)N)N)C(=O)O GJFYPBDMUGGLFR-NKWVEPMBSA-N 0.000 description 1
- XVBDDUPJVQXDSI-PEFMBERDSA-N Asn-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N XVBDDUPJVQXDSI-PEFMBERDSA-N 0.000 description 1
- GQRDIVQPSMPQME-ZPFDUUQYSA-N Asn-Ile-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O GQRDIVQPSMPQME-ZPFDUUQYSA-N 0.000 description 1
- LTZIRYMWOJHRCH-GUDRVLHUSA-N Asn-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N LTZIRYMWOJHRCH-GUDRVLHUSA-N 0.000 description 1
- HFPXZWPUVFVNLL-GUBZILKMSA-N Asn-Leu-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O HFPXZWPUVFVNLL-GUBZILKMSA-N 0.000 description 1
- FBODFHMLALOPHP-GUBZILKMSA-N Asn-Lys-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O FBODFHMLALOPHP-GUBZILKMSA-N 0.000 description 1
- RZNAMKZJPBQWDJ-SRVKXCTJSA-N Asn-Lys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)N RZNAMKZJPBQWDJ-SRVKXCTJSA-N 0.000 description 1
- RVHGJNGNKGDCPX-KKUMJFAQSA-N Asn-Phe-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N RVHGJNGNKGDCPX-KKUMJFAQSA-N 0.000 description 1
- ZJIFRAPZHAGLGR-MELADBBJSA-N Asn-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)N)N)C(=O)O ZJIFRAPZHAGLGR-MELADBBJSA-N 0.000 description 1
- VCJCPARXDBEGNE-GUBZILKMSA-N Asn-Pro-Pro Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 VCJCPARXDBEGNE-GUBZILKMSA-N 0.000 description 1
- KVMPVNGOKHTUHZ-GCJQMDKQSA-N Asp-Ala-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KVMPVNGOKHTUHZ-GCJQMDKQSA-N 0.000 description 1
- VBVKSAFJPVXMFJ-CIUDSAMLSA-N Asp-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N VBVKSAFJPVXMFJ-CIUDSAMLSA-N 0.000 description 1
- WKGJGVGTEZGFSW-FXQIFTODSA-N Asp-Asn-Met Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O WKGJGVGTEZGFSW-FXQIFTODSA-N 0.000 description 1
- QXHVOUSPVAWEMX-ZLUOBGJFSA-N Asp-Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O QXHVOUSPVAWEMX-ZLUOBGJFSA-N 0.000 description 1
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 1
- JUWZKMBALYLZCK-WHFBIAKZSA-N Asp-Gly-Asn Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O JUWZKMBALYLZCK-WHFBIAKZSA-N 0.000 description 1
- VIRHEUMYXXLCBF-WDSKDSINSA-N Asp-Gly-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O VIRHEUMYXXLCBF-WDSKDSINSA-N 0.000 description 1
- OMMIEVATLAGRCK-BYPYZUCNSA-N Asp-Gly-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)NCC(O)=O OMMIEVATLAGRCK-BYPYZUCNSA-N 0.000 description 1
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 1
- WSGVTKZFVJSJOG-RCOVLWMOSA-N Asp-Gly-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O WSGVTKZFVJSJOG-RCOVLWMOSA-N 0.000 description 1
- SWTQDYFZVOJVLL-KKUMJFAQSA-N Asp-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)O)N)O SWTQDYFZVOJVLL-KKUMJFAQSA-N 0.000 description 1
- NHSDEZURHWEZPN-SXTJYALSSA-N Asp-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC(=O)O)N NHSDEZURHWEZPN-SXTJYALSSA-N 0.000 description 1
- GKWFMNNNYZHJHV-SRVKXCTJSA-N Asp-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(O)=O GKWFMNNNYZHJHV-SRVKXCTJSA-N 0.000 description 1
- JUWISGAGWSDGDH-KKUMJFAQSA-N Asp-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=CC=C1 JUWISGAGWSDGDH-KKUMJFAQSA-N 0.000 description 1
- VNXQRBXEQXLERQ-CIUDSAMLSA-N Asp-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N VNXQRBXEQXLERQ-CIUDSAMLSA-N 0.000 description 1
- GCACQYDBDHRVGE-LKXGYXEUSA-N Asp-Thr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC(O)=O GCACQYDBDHRVGE-LKXGYXEUSA-N 0.000 description 1
- 108010083946 Asp-Tyr-Leu-Lys Proteins 0.000 description 1
- BJDHEININLSZOT-KKUMJFAQSA-N Asp-Tyr-Lys Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(O)=O BJDHEININLSZOT-KKUMJFAQSA-N 0.000 description 1
- CZXWOKHVLNYAHI-UHFFFAOYSA-N CBDVA Natural products OC1=C(C(O)=O)C(CCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 CZXWOKHVLNYAHI-UHFFFAOYSA-N 0.000 description 1
- 101100205030 Caenorhabditis elegans hars-1 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- SKSJPIBFNFPTJB-NKWVEPMBSA-N Cys-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CS)N)C(=O)O SKSJPIBFNFPTJB-NKWVEPMBSA-N 0.000 description 1
- LBSKYJOZIIOZIO-DCAQKATOSA-N Cys-Lys-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N LBSKYJOZIIOZIO-DCAQKATOSA-N 0.000 description 1
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000048120 Galactokinases Human genes 0.000 description 1
- 108700023157 Galactokinases Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 102000013404 Geranyltranstransferase Human genes 0.000 description 1
- 108010026318 Geranyltranstransferase Proteins 0.000 description 1
- PRBLYKYHAJEABA-SRVKXCTJSA-N Gln-Arg-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O PRBLYKYHAJEABA-SRVKXCTJSA-N 0.000 description 1
- KZEUVLLVULIPNX-GUBZILKMSA-N Gln-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N KZEUVLLVULIPNX-GUBZILKMSA-N 0.000 description 1
- CITDWMLWXNUQKD-FXQIFTODSA-N Gln-Gln-Asn Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CITDWMLWXNUQKD-FXQIFTODSA-N 0.000 description 1
- HYPVLWGNBIYTNA-GUBZILKMSA-N Gln-Leu-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HYPVLWGNBIYTNA-GUBZILKMSA-N 0.000 description 1
- JNENSVNAUWONEZ-GUBZILKMSA-N Gln-Lys-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O JNENSVNAUWONEZ-GUBZILKMSA-N 0.000 description 1
- JRHPEMVLTRADLJ-AVGNSLFASA-N Gln-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N JRHPEMVLTRADLJ-AVGNSLFASA-N 0.000 description 1
- DBNLXHGDGBUCDV-KKUMJFAQSA-N Gln-Phe-Met Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(O)=O DBNLXHGDGBUCDV-KKUMJFAQSA-N 0.000 description 1
- PAOHIZNRJNIXQY-XQXXSGGOSA-N Gln-Thr-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O PAOHIZNRJNIXQY-XQXXSGGOSA-N 0.000 description 1
- HLRLXVPRJJITSK-IFFSRLJSSA-N Gln-Thr-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HLRLXVPRJJITSK-IFFSRLJSSA-N 0.000 description 1
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 1
- MXOODARRORARSU-ACZMJKKPSA-N Glu-Ala-Ser Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N MXOODARRORARSU-ACZMJKKPSA-N 0.000 description 1
- NCWOMXABNYEPLY-NRPADANISA-N Glu-Ala-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O NCWOMXABNYEPLY-NRPADANISA-N 0.000 description 1
- KKCUFHUTMKQQCF-SRVKXCTJSA-N Glu-Arg-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O KKCUFHUTMKQQCF-SRVKXCTJSA-N 0.000 description 1
- SRZLHYPAOXBBSB-HJGDQZAQSA-N Glu-Arg-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SRZLHYPAOXBBSB-HJGDQZAQSA-N 0.000 description 1
- CKRUHITYRFNUKW-WDSKDSINSA-N Glu-Asn-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CKRUHITYRFNUKW-WDSKDSINSA-N 0.000 description 1
- ZJICFHQSPWFBKP-AVGNSLFASA-N Glu-Asn-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZJICFHQSPWFBKP-AVGNSLFASA-N 0.000 description 1
- HUFCEIHAFNVSNR-IHRRRGAJSA-N Glu-Gln-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HUFCEIHAFNVSNR-IHRRRGAJSA-N 0.000 description 1
- SJPMNHCEWPTRBR-BQBZGAKWSA-N Glu-Glu-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O SJPMNHCEWPTRBR-BQBZGAKWSA-N 0.000 description 1
- LGYZYFFDELZWRS-DCAQKATOSA-N Glu-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O LGYZYFFDELZWRS-DCAQKATOSA-N 0.000 description 1
- PXXGVUVQWQGGIG-YUMQZZPRSA-N Glu-Gly-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N PXXGVUVQWQGGIG-YUMQZZPRSA-N 0.000 description 1
- OGNJZUXUTPQVBR-BQBZGAKWSA-N Glu-Gly-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OGNJZUXUTPQVBR-BQBZGAKWSA-N 0.000 description 1
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 1
- ZWQVYZXPYSYPJD-RYUDHWBXSA-N Glu-Gly-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZWQVYZXPYSYPJD-RYUDHWBXSA-N 0.000 description 1
- RAUDKMVXNOWDLS-WDSKDSINSA-N Glu-Gly-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O RAUDKMVXNOWDLS-WDSKDSINSA-N 0.000 description 1
- HPJLZFTUUJKWAJ-JHEQGTHGSA-N Glu-Gly-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HPJLZFTUUJKWAJ-JHEQGTHGSA-N 0.000 description 1
- XMPAXPSENRSOSV-RYUDHWBXSA-N Glu-Gly-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XMPAXPSENRSOSV-RYUDHWBXSA-N 0.000 description 1
- VGOFRWOTSXVPAU-SDDRHHMPSA-N Glu-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCC(=O)O)N)C(=O)O VGOFRWOTSXVPAU-SDDRHHMPSA-N 0.000 description 1
- ZWABFSSWTSAMQN-KBIXCLLPSA-N Glu-Ile-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O ZWABFSSWTSAMQN-KBIXCLLPSA-N 0.000 description 1
- XTZDZAXYPDISRR-MNXVOIDGSA-N Glu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XTZDZAXYPDISRR-MNXVOIDGSA-N 0.000 description 1
- GXMXPCXXKVWOSM-KQXIARHKSA-N Glu-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N GXMXPCXXKVWOSM-KQXIARHKSA-N 0.000 description 1
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 1
- PJBVXVBTTFZPHJ-GUBZILKMSA-N Glu-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N PJBVXVBTTFZPHJ-GUBZILKMSA-N 0.000 description 1
- IVGJYOOGJLFKQE-AVGNSLFASA-N Glu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N IVGJYOOGJLFKQE-AVGNSLFASA-N 0.000 description 1
- CUPSDFQZTVVTSK-GUBZILKMSA-N Glu-Lys-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O CUPSDFQZTVVTSK-GUBZILKMSA-N 0.000 description 1
- JDUKCSSHWNIQQZ-IHRRRGAJSA-N Glu-Phe-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O JDUKCSSHWNIQQZ-IHRRRGAJSA-N 0.000 description 1
- QNJNPKSWAHPYGI-JYJNAYRXSA-N Glu-Phe-Leu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=CC=C1 QNJNPKSWAHPYGI-JYJNAYRXSA-N 0.000 description 1
- CHDWDBPJOZVZSE-KKUMJFAQSA-N Glu-Phe-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(O)=O CHDWDBPJOZVZSE-KKUMJFAQSA-N 0.000 description 1
- ARIORLIIMJACKZ-KKUMJFAQSA-N Glu-Pro-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ARIORLIIMJACKZ-KKUMJFAQSA-N 0.000 description 1
- QGAJQIGFFIQJJK-IHRRRGAJSA-N Glu-Tyr-Gln Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O QGAJQIGFFIQJJK-IHRRRGAJSA-N 0.000 description 1
- HQTDNEZTGZUWSY-XVKPBYJWSA-N Glu-Val-Gly Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)NCC(O)=O HQTDNEZTGZUWSY-XVKPBYJWSA-N 0.000 description 1
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 1
- JRDYDYXZKFNNRQ-XPUUQOCRSA-N Gly-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN JRDYDYXZKFNNRQ-XPUUQOCRSA-N 0.000 description 1
- KRRMJKMGWWXWDW-STQMWFEESA-N Gly-Arg-Phe Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KRRMJKMGWWXWDW-STQMWFEESA-N 0.000 description 1
- VXKCPBPQEKKERH-IUCAKERBSA-N Gly-Arg-Pro Chemical compound NC(N)=NCCC[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O VXKCPBPQEKKERH-IUCAKERBSA-N 0.000 description 1
- PMNHJLASAAWELO-FOHZUACHSA-N Gly-Asp-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PMNHJLASAAWELO-FOHZUACHSA-N 0.000 description 1
- TZOVVRJYUDETQG-RCOVLWMOSA-N Gly-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN TZOVVRJYUDETQG-RCOVLWMOSA-N 0.000 description 1
- PABFFPWEJMEVEC-JGVFFNPUSA-N Gly-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)CN)C(=O)O PABFFPWEJMEVEC-JGVFFNPUSA-N 0.000 description 1
- MBOAPAXLTUSMQI-JHEQGTHGSA-N Gly-Glu-Thr Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MBOAPAXLTUSMQI-JHEQGTHGSA-N 0.000 description 1
- PDAWDNVHMUKWJR-ZETCQYMHSA-N Gly-Gly-His Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CNC=N1 PDAWDNVHMUKWJR-ZETCQYMHSA-N 0.000 description 1
- QPCVIQJVRGXUSA-LURJTMIESA-N Gly-Gly-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)CNC(=O)CN QPCVIQJVRGXUSA-LURJTMIESA-N 0.000 description 1
- OLPPXYMMIARYAL-QMMMGPOBSA-N Gly-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)CN OLPPXYMMIARYAL-QMMMGPOBSA-N 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- DGKBSGNCMCLDSL-BYULHYEWSA-N Gly-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN DGKBSGNCMCLDSL-BYULHYEWSA-N 0.000 description 1
- ITZOBNKQDZEOCE-NHCYSSNCSA-N Gly-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CN ITZOBNKQDZEOCE-NHCYSSNCSA-N 0.000 description 1
- SCWYHUQOOFRVHP-MBLNEYKQSA-N Gly-Ile-Thr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SCWYHUQOOFRVHP-MBLNEYKQSA-N 0.000 description 1
- PAWIVEIWWYGBAM-YUMQZZPRSA-N Gly-Leu-Ala Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O PAWIVEIWWYGBAM-YUMQZZPRSA-N 0.000 description 1
- MHXKHKWHPNETGG-QWRGUYRKSA-N Gly-Lys-Leu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O MHXKHKWHPNETGG-QWRGUYRKSA-N 0.000 description 1
- YLEIWGJJBFBFHC-KBPBESRZSA-N Gly-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 YLEIWGJJBFBFHC-KBPBESRZSA-N 0.000 description 1
- POJJAZJHBGXEGM-YUMQZZPRSA-N Gly-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN POJJAZJHBGXEGM-YUMQZZPRSA-N 0.000 description 1
- ZLCLYFGMKFCDCN-XPUUQOCRSA-N Gly-Ser-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(O)=O ZLCLYFGMKFCDCN-XPUUQOCRSA-N 0.000 description 1
- UIQGJYUEQDOODF-KWQFWETISA-N Gly-Tyr-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 UIQGJYUEQDOODF-KWQFWETISA-N 0.000 description 1
- YJDALMUYJIENAG-QWRGUYRKSA-N Gly-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN)O YJDALMUYJIENAG-QWRGUYRKSA-N 0.000 description 1
- DNVDEMWIYLVIQU-RCOVLWMOSA-N Gly-Val-Asp Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O DNVDEMWIYLVIQU-RCOVLWMOSA-N 0.000 description 1
- AFMOTCMSEBITOE-YEPSODPASA-N Gly-Val-Thr Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AFMOTCMSEBITOE-YEPSODPASA-N 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 1
- MDBYBTWRMOAJAY-NHCYSSNCSA-N His-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CN=CN1)N MDBYBTWRMOAJAY-NHCYSSNCSA-N 0.000 description 1
- LYSMQLXUCAKELQ-DCAQKATOSA-N His-Asp-Arg Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N LYSMQLXUCAKELQ-DCAQKATOSA-N 0.000 description 1
- WGVPDSNCHDEDBP-KKUMJFAQSA-N His-Asp-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WGVPDSNCHDEDBP-KKUMJFAQSA-N 0.000 description 1
- WEIYKCOEVBUJQC-JYJNAYRXSA-N His-Glu-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CN=CN2)N WEIYKCOEVBUJQC-JYJNAYRXSA-N 0.000 description 1
- QAMFAYSMNZBNCA-UWVGGRQHSA-N His-Gly-Met Chemical compound CSCC[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(O)=O QAMFAYSMNZBNCA-UWVGGRQHSA-N 0.000 description 1
- PMWSGVRIMIFXQH-KKUMJFAQSA-N His-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1NC=NC=1)C1=CN=CN1 PMWSGVRIMIFXQH-KKUMJFAQSA-N 0.000 description 1
- LVWIJITYHRZHBO-IXOXFDKPSA-N His-Leu-Thr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LVWIJITYHRZHBO-IXOXFDKPSA-N 0.000 description 1
- YYOCMTFVGKDNQP-IHRRRGAJSA-N His-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N YYOCMTFVGKDNQP-IHRRRGAJSA-N 0.000 description 1
- ILUVWFTXAUYOBW-CUJWVEQBSA-N His-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CN=CN1)N)O ILUVWFTXAUYOBW-CUJWVEQBSA-N 0.000 description 1
- 101000934858 Homo sapiens Breast cancer type 2 susceptibility protein Proteins 0.000 description 1
- 101000963523 Homo sapiens Magnesium transporter MRS2 homolog, mitochondrial Proteins 0.000 description 1
- 101000664600 Homo sapiens Tripartite motif-containing protein 3 Proteins 0.000 description 1
- MKWSZEHGHSLNPF-NAKRPEOUSA-N Ile-Ala-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O)N MKWSZEHGHSLNPF-NAKRPEOUSA-N 0.000 description 1
- LVQDUPQUJZWKSU-PYJNHQTQSA-N Ile-Arg-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LVQDUPQUJZWKSU-PYJNHQTQSA-N 0.000 description 1
- UDLAWRKOVFDKFL-PEFMBERDSA-N Ile-Asp-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N UDLAWRKOVFDKFL-PEFMBERDSA-N 0.000 description 1
- VOBYAKCXGQQFLR-LSJOCFKGSA-N Ile-Gly-Val Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O VOBYAKCXGQQFLR-LSJOCFKGSA-N 0.000 description 1
- YBGTWSFIGHUWQE-MXAVVETBSA-N Ile-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)CC)CC1=CN=CN1 YBGTWSFIGHUWQE-MXAVVETBSA-N 0.000 description 1
- OUUCIIJSBIBCHB-ZPFDUUQYSA-N Ile-Leu-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O OUUCIIJSBIBCHB-ZPFDUUQYSA-N 0.000 description 1
- UDBPXJNOEWDBDF-XUXIUFHCSA-N Ile-Lys-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O)N UDBPXJNOEWDBDF-XUXIUFHCSA-N 0.000 description 1
- FTUZWJVSNZMLPI-RVMXOQNASA-N Ile-Met-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@@H]1C(=O)O)N FTUZWJVSNZMLPI-RVMXOQNASA-N 0.000 description 1
- WCNWGAUZWWSYDG-SVSWQMSJSA-N Ile-Thr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O)N WCNWGAUZWWSYDG-SVSWQMSJSA-N 0.000 description 1
- XVUAQNRNFMVWBR-BLMTYFJBSA-N Ile-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N XVUAQNRNFMVWBR-BLMTYFJBSA-N 0.000 description 1
- ZUWSVOYKBCHLRR-MGHWNKPDSA-N Ile-Tyr-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)O)N ZUWSVOYKBCHLRR-MGHWNKPDSA-N 0.000 description 1
- HODVZHLJUUWPKY-STECZYCISA-N Ile-Tyr-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)CC)CC1=CC=C(O)C=C1 HODVZHLJUUWPKY-STECZYCISA-N 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- CQQGCWPXDHTTNF-GUBZILKMSA-N Leu-Ala-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O CQQGCWPXDHTTNF-GUBZILKMSA-N 0.000 description 1
- KWTVLKBOQATPHJ-SRVKXCTJSA-N Leu-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N KWTVLKBOQATPHJ-SRVKXCTJSA-N 0.000 description 1
- KTFHTMHHKXUYPW-ZPFDUUQYSA-N Leu-Asp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KTFHTMHHKXUYPW-ZPFDUUQYSA-N 0.000 description 1
- MYGQXVYRZMKRDB-SRVKXCTJSA-N Leu-Asp-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN MYGQXVYRZMKRDB-SRVKXCTJSA-N 0.000 description 1
- ZYLJULGXQDNXDK-GUBZILKMSA-N Leu-Gln-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ZYLJULGXQDNXDK-GUBZILKMSA-N 0.000 description 1
- LAGPXKYZCCTSGQ-JYJNAYRXSA-N Leu-Glu-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LAGPXKYZCCTSGQ-JYJNAYRXSA-N 0.000 description 1
- LLBQJYDYOLIQAI-JYJNAYRXSA-N Leu-Glu-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LLBQJYDYOLIQAI-JYJNAYRXSA-N 0.000 description 1
- DBSLVQBXKVKDKJ-BJDJZHNGSA-N Leu-Ile-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O DBSLVQBXKVKDKJ-BJDJZHNGSA-N 0.000 description 1
- HNDWYLYAYNBWMP-AJNGGQMLSA-N Leu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N HNDWYLYAYNBWMP-AJNGGQMLSA-N 0.000 description 1
- NRFGTHFONZYFNY-MGHWNKPDSA-N Leu-Ile-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NRFGTHFONZYFNY-MGHWNKPDSA-N 0.000 description 1
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 1
- BGZCJDGBBUUBHA-KKUMJFAQSA-N Leu-Lys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O BGZCJDGBBUUBHA-KKUMJFAQSA-N 0.000 description 1
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 1
- MJTOYIHCKVQICL-ULQDDVLXSA-N Leu-Met-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N MJTOYIHCKVQICL-ULQDDVLXSA-N 0.000 description 1
- PJWOOBTYQNNRBF-BZSNNMDCSA-N Leu-Phe-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)O)N PJWOOBTYQNNRBF-BZSNNMDCSA-N 0.000 description 1
- YWKNKRAKOCLOLH-OEAJRASXSA-N Leu-Phe-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YWKNKRAKOCLOLH-OEAJRASXSA-N 0.000 description 1
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 1
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 1
- ODRREERHVHMIPT-OEAJRASXSA-N Leu-Thr-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ODRREERHVHMIPT-OEAJRASXSA-N 0.000 description 1
- AXVIGSRGTMNSJU-YESZJQIVSA-N Leu-Tyr-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N AXVIGSRGTMNSJU-YESZJQIVSA-N 0.000 description 1
- XZNJZXJZBMBGGS-NHCYSSNCSA-N Leu-Val-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O XZNJZXJZBMBGGS-NHCYSSNCSA-N 0.000 description 1
- CGHXMODRYJISSK-NHCYSSNCSA-N Leu-Val-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O CGHXMODRYJISSK-NHCYSSNCSA-N 0.000 description 1
- 229910013594 LiOAc Inorganic materials 0.000 description 1
- XFIHDSBIPWEYJJ-YUMQZZPRSA-N Lys-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN XFIHDSBIPWEYJJ-YUMQZZPRSA-N 0.000 description 1
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 1
- YIBOAHAOAWACDK-QEJZJMRPSA-N Lys-Ala-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YIBOAHAOAWACDK-QEJZJMRPSA-N 0.000 description 1
- VHXMZJGOKIMETG-CQDKDKBSSA-N Lys-Ala-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CCCCN)N VHXMZJGOKIMETG-CQDKDKBSSA-N 0.000 description 1
- GKFNXYMAMKJSKD-NHCYSSNCSA-N Lys-Asp-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O GKFNXYMAMKJSKD-NHCYSSNCSA-N 0.000 description 1
- DUTMKEAPLLUGNO-JYJNAYRXSA-N Lys-Glu-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O DUTMKEAPLLUGNO-JYJNAYRXSA-N 0.000 description 1
- LCMWVZLBCUVDAZ-IUCAKERBSA-N Lys-Gly-Glu Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)NCC(=O)N[C@H](C([O-])=O)CCC([O-])=O LCMWVZLBCUVDAZ-IUCAKERBSA-N 0.000 description 1
- GNLJXWBNLAIPEP-MELADBBJSA-N Lys-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCCCN)N)C(=O)O GNLJXWBNLAIPEP-MELADBBJSA-N 0.000 description 1
- JYXBNQOKPRQNQS-YTFOTSKYSA-N Lys-Ile-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JYXBNQOKPRQNQS-YTFOTSKYSA-N 0.000 description 1
- NJNRBRKHOWSGMN-SRVKXCTJSA-N Lys-Leu-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O NJNRBRKHOWSGMN-SRVKXCTJSA-N 0.000 description 1
- MUXNCRWTWBMNHX-SRVKXCTJSA-N Lys-Leu-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O MUXNCRWTWBMNHX-SRVKXCTJSA-N 0.000 description 1
- WVJNGSFKBKOKRV-AJNGGQMLSA-N Lys-Leu-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WVJNGSFKBKOKRV-AJNGGQMLSA-N 0.000 description 1
- YPLVCBKEPJPBDQ-MELADBBJSA-N Lys-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N YPLVCBKEPJPBDQ-MELADBBJSA-N 0.000 description 1
- WRODMZBHNNPRLN-SRVKXCTJSA-N Lys-Leu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O WRODMZBHNNPRLN-SRVKXCTJSA-N 0.000 description 1
- LJADEBULDNKJNK-IHRRRGAJSA-N Lys-Leu-Val Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O LJADEBULDNKJNK-IHRRRGAJSA-N 0.000 description 1
- ATNKHRAIZCMCCN-BZSNNMDCSA-N Lys-Lys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N ATNKHRAIZCMCCN-BZSNNMDCSA-N 0.000 description 1
- PLDJDCJLRCYPJB-VOAKCMCISA-N Lys-Lys-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PLDJDCJLRCYPJB-VOAKCMCISA-N 0.000 description 1
- ZJSZPXISKMDJKQ-JYJNAYRXSA-N Lys-Phe-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(O)=O)CC1=CC=CC=C1 ZJSZPXISKMDJKQ-JYJNAYRXSA-N 0.000 description 1
- LMGNWHDWJDIOPK-DKIMLUQUSA-N Lys-Phe-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LMGNWHDWJDIOPK-DKIMLUQUSA-N 0.000 description 1
- LUAJJLPHUXPQLH-KKUMJFAQSA-N Lys-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCCN)N LUAJJLPHUXPQLH-KKUMJFAQSA-N 0.000 description 1
- HYSVGEAWTGPMOA-IHRRRGAJSA-N Lys-Pro-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O HYSVGEAWTGPMOA-IHRRRGAJSA-N 0.000 description 1
- LECIJRIRMVOFMH-ULQDDVLXSA-N Lys-Pro-Phe Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 LECIJRIRMVOFMH-ULQDDVLXSA-N 0.000 description 1
- YSPZCHGIWAQVKQ-AVGNSLFASA-N Lys-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN YSPZCHGIWAQVKQ-AVGNSLFASA-N 0.000 description 1
- HKXSZKJMDBHOTG-CIUDSAMLSA-N Lys-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN HKXSZKJMDBHOTG-CIUDSAMLSA-N 0.000 description 1
- VKCPHIOZDWUFSW-ONGXEEELSA-N Lys-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN VKCPHIOZDWUFSW-ONGXEEELSA-N 0.000 description 1
- NYTDJEZBAAFLLG-IHRRRGAJSA-N Lys-Val-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O NYTDJEZBAAFLLG-IHRRRGAJSA-N 0.000 description 1
- 102100039143 Magnesium transporter MRS2 homolog, mitochondrial Human genes 0.000 description 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
- WXHHTBVYQOSYSL-FXQIFTODSA-N Met-Ala-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O WXHHTBVYQOSYSL-FXQIFTODSA-N 0.000 description 1
- OLWAOWXIADGIJG-AVGNSLFASA-N Met-Arg-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(O)=O OLWAOWXIADGIJG-AVGNSLFASA-N 0.000 description 1
- DCHHUGLTVLJYKA-FXQIFTODSA-N Met-Asn-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O DCHHUGLTVLJYKA-FXQIFTODSA-N 0.000 description 1
- UAPZLLPGGOOCRO-IHRRRGAJSA-N Met-Asn-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N UAPZLLPGGOOCRO-IHRRRGAJSA-N 0.000 description 1
- JACAKCWAOHKQBV-UWVGGRQHSA-N Met-Gly-Lys Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN JACAKCWAOHKQBV-UWVGGRQHSA-N 0.000 description 1
- HOZNVKDCKZPRER-XUXIUFHCSA-N Met-Lys-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HOZNVKDCKZPRER-XUXIUFHCSA-N 0.000 description 1
- RDLSEGZJMYGFNS-FXQIFTODSA-N Met-Ser-Asp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RDLSEGZJMYGFNS-FXQIFTODSA-N 0.000 description 1
- WXJLBSXNUHIGSS-OSUNSFLBSA-N Met-Thr-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WXJLBSXNUHIGSS-OSUNSFLBSA-N 0.000 description 1
- VYXIKLFLGRTANT-HRCADAONSA-N Met-Tyr-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N VYXIKLFLGRTANT-HRCADAONSA-N 0.000 description 1
- QAVZUKIPOMBLMC-AVGNSLFASA-N Met-Val-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(C)C QAVZUKIPOMBLMC-AVGNSLFASA-N 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 1
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108010087066 N2-tryptophyllysine Proteins 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- KAHUBGWSIQNZQQ-KKUMJFAQSA-N Phe-Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KAHUBGWSIQNZQQ-KKUMJFAQSA-N 0.000 description 1
- SWZKMTDPQXLQRD-XVSYOHENSA-N Phe-Asp-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWZKMTDPQXLQRD-XVSYOHENSA-N 0.000 description 1
- ABQFNJAFONNUTH-FHWLQOOXSA-N Phe-Gln-Tyr Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N ABQFNJAFONNUTH-FHWLQOOXSA-N 0.000 description 1
- MPFGIYLYWUCSJG-AVGNSLFASA-N Phe-Glu-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MPFGIYLYWUCSJG-AVGNSLFASA-N 0.000 description 1
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 1
- JQLQUPIYYJXZLJ-ZEWNOJEFSA-N Phe-Ile-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 JQLQUPIYYJXZLJ-ZEWNOJEFSA-N 0.000 description 1
- OQTDZEJJWWAGJT-KKUMJFAQSA-N Phe-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O OQTDZEJJWWAGJT-KKUMJFAQSA-N 0.000 description 1
- BSHMIVKDJQGLNT-ACRUOGEOSA-N Phe-Lys-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 BSHMIVKDJQGLNT-ACRUOGEOSA-N 0.000 description 1
- QARPMYDMYVLFMW-KKUMJFAQSA-N Phe-Pro-Glu Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=CC=C1 QARPMYDMYVLFMW-KKUMJFAQSA-N 0.000 description 1
- NJJBATPLUQHRBM-IHRRRGAJSA-N Phe-Pro-Ser Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@@H](CO)C(=O)O NJJBATPLUQHRBM-IHRRRGAJSA-N 0.000 description 1
- WEDZFLRYSIDIRX-IHRRRGAJSA-N Phe-Ser-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C1 WEDZFLRYSIDIRX-IHRRRGAJSA-N 0.000 description 1
- BPIFSOUEUYDJRM-DCPHZVHLSA-N Phe-Trp-Ala Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(O)=O)C1=CC=CC=C1 BPIFSOUEUYDJRM-DCPHZVHLSA-N 0.000 description 1
- DEDANIDYQAPTFI-IHRRRGAJSA-N Pro-Asp-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O DEDANIDYQAPTFI-IHRRRGAJSA-N 0.000 description 1
- UAYHMOIGIQZLFR-NHCYSSNCSA-N Pro-Gln-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O UAYHMOIGIQZLFR-NHCYSSNCSA-N 0.000 description 1
- AFXCXDQNRXTSBD-FJXKBIBVSA-N Pro-Gly-Thr Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O AFXCXDQNRXTSBD-FJXKBIBVSA-N 0.000 description 1
- VZKBJNBZMZHKRC-XUXIUFHCSA-N Pro-Ile-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O VZKBJNBZMZHKRC-XUXIUFHCSA-N 0.000 description 1
- KWMZPPWYBVZIER-XGEHTFHBSA-N Pro-Ser-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWMZPPWYBVZIER-XGEHTFHBSA-N 0.000 description 1
- JXVXYRZQIUPYSA-NHCYSSNCSA-N Pro-Val-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JXVXYRZQIUPYSA-NHCYSSNCSA-N 0.000 description 1
- XRGIDCGRSSWCKE-SRVKXCTJSA-N Pro-Val-Met Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O XRGIDCGRSSWCKE-SRVKXCTJSA-N 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 102000048125 Riboflavin kinases Human genes 0.000 description 1
- 101100174613 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) TDH3 gene Proteins 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- YMEXHZTVKDAKIY-GHCJXIJMSA-N Ser-Asn-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(O)=O YMEXHZTVKDAKIY-GHCJXIJMSA-N 0.000 description 1
- BNFVPSRLHHPQKS-WHFBIAKZSA-N Ser-Asp-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O BNFVPSRLHHPQKS-WHFBIAKZSA-N 0.000 description 1
- PVDTYLHUWAEYGY-CIUDSAMLSA-N Ser-Glu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PVDTYLHUWAEYGY-CIUDSAMLSA-N 0.000 description 1
- HJEBZBMOTCQYDN-ACZMJKKPSA-N Ser-Glu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HJEBZBMOTCQYDN-ACZMJKKPSA-N 0.000 description 1
- AEGUWTFAQQWVLC-BQBZGAKWSA-N Ser-Gly-Arg Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O AEGUWTFAQQWVLC-BQBZGAKWSA-N 0.000 description 1
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 1
- SFTZTYBXIXLRGQ-JBDRJPRFSA-N Ser-Ile-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SFTZTYBXIXLRGQ-JBDRJPRFSA-N 0.000 description 1
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 1
- RWDVVSKYZBNDCO-MELADBBJSA-N Ser-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)N)C(=O)O RWDVVSKYZBNDCO-MELADBBJSA-N 0.000 description 1
- 101000848282 Siganus canaliculatus Acyl-CoA Delta-6 desaturase Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- IQSYWEWTWDEVNO-UHFFFAOYSA-N THCVA Natural products O1C(C)(C)C2CCC(C)=CC2C2=C1C=C(CCC)C(C(O)=O)=C2O IQSYWEWTWDEVNO-UHFFFAOYSA-N 0.000 description 1
- 102100036407 Thioredoxin Human genes 0.000 description 1
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 1
- DCLBXIWHLVEPMQ-JRQIVUDYSA-N Thr-Asp-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DCLBXIWHLVEPMQ-JRQIVUDYSA-N 0.000 description 1
- LIXBDERDAGNVAV-XKBZYTNZSA-N Thr-Gln-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O LIXBDERDAGNVAV-XKBZYTNZSA-N 0.000 description 1
- KGKWKSSSQGGYAU-SUSMZKCASA-N Thr-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KGKWKSSSQGGYAU-SUSMZKCASA-N 0.000 description 1
- UYTYTDMCDBPDSC-URLPEUOOSA-N Thr-Ile-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N UYTYTDMCDBPDSC-URLPEUOOSA-N 0.000 description 1
- XYFISNXATOERFZ-OSUNSFLBSA-N Thr-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N XYFISNXATOERFZ-OSUNSFLBSA-N 0.000 description 1
- JLNMFGCJODTXDH-WEDXCCLWSA-N Thr-Lys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O JLNMFGCJODTXDH-WEDXCCLWSA-N 0.000 description 1
- MCDVZTRGHNXTGK-HJGDQZAQSA-N Thr-Met-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O MCDVZTRGHNXTGK-HJGDQZAQSA-N 0.000 description 1
- VGYVVSQFSSKZRJ-OEAJRASXSA-N Thr-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@H](O)C)CC1=CC=CC=C1 VGYVVSQFSSKZRJ-OEAJRASXSA-N 0.000 description 1
- NDXSOKGYKCGYKT-VEVYYDQMSA-N Thr-Pro-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O NDXSOKGYKCGYKT-VEVYYDQMSA-N 0.000 description 1
- VTMGKRABARCZAX-OSUNSFLBSA-N Thr-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O VTMGKRABARCZAX-OSUNSFLBSA-N 0.000 description 1
- BCYUHPXBHCUYBA-CUJWVEQBSA-N Thr-Ser-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O BCYUHPXBHCUYBA-CUJWVEQBSA-N 0.000 description 1
- UQCNIMDPYICBTR-KYNKHSRBSA-N Thr-Thr-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O UQCNIMDPYICBTR-KYNKHSRBSA-N 0.000 description 1
- GRIUMVXCJDKVPI-IZPVPAKOSA-N Thr-Thr-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GRIUMVXCJDKVPI-IZPVPAKOSA-N 0.000 description 1
- XGUAUKUYQHBUNY-SWRJLBSHSA-N Thr-Trp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O XGUAUKUYQHBUNY-SWRJLBSHSA-N 0.000 description 1
- PELIQFPESHBTMA-WLTAIBSBSA-N Thr-Tyr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 PELIQFPESHBTMA-WLTAIBSBSA-N 0.000 description 1
- OGOYMQWIWHGTGH-KZVJFYERSA-N Thr-Val-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O OGOYMQWIWHGTGH-KZVJFYERSA-N 0.000 description 1
- KZTLZZQTJMCGIP-ZJDVBMNYSA-N Thr-Val-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KZTLZZQTJMCGIP-ZJDVBMNYSA-N 0.000 description 1
- 101710195626 Transcriptional activator protein Proteins 0.000 description 1
- 102100038798 Tripartite motif-containing protein 3 Human genes 0.000 description 1
- MQVGIFJSFFVGFW-XEGUGMAKSA-N Trp-Ala-Glu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O MQVGIFJSFFVGFW-XEGUGMAKSA-N 0.000 description 1
- HJWVPKJHHLZCNH-DVXDUOKCSA-N Trp-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC=3C4=CC=CC=C4NC=3)C)C(O)=O)=CNC2=C1 HJWVPKJHHLZCNH-DVXDUOKCSA-N 0.000 description 1
- XLMDWQNAOKLKCP-XDTLVQLUSA-N Tyr-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N XLMDWQNAOKLKCP-XDTLVQLUSA-N 0.000 description 1
- GFHYISDTIWZUSU-QWRGUYRKSA-N Tyr-Asn-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GFHYISDTIWZUSU-QWRGUYRKSA-N 0.000 description 1
- SCCKSNREWHMKOJ-SRVKXCTJSA-N Tyr-Asn-Ser Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O SCCKSNREWHMKOJ-SRVKXCTJSA-N 0.000 description 1
- GAYLGYUVTDMLKC-UWJYBYFXSA-N Tyr-Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GAYLGYUVTDMLKC-UWJYBYFXSA-N 0.000 description 1
- NLMXVDDEQFKQQU-CFMVVWHZSA-N Tyr-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NLMXVDDEQFKQQU-CFMVVWHZSA-N 0.000 description 1
- XQYHLZNPOTXRMQ-KKUMJFAQSA-N Tyr-Glu-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O XQYHLZNPOTXRMQ-KKUMJFAQSA-N 0.000 description 1
- WVRUKYLYMFGKAN-IHRRRGAJSA-N Tyr-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 WVRUKYLYMFGKAN-IHRRRGAJSA-N 0.000 description 1
- HVHJYXDXRIWELT-RYUDHWBXSA-N Tyr-Glu-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O HVHJYXDXRIWELT-RYUDHWBXSA-N 0.000 description 1
- FNWGDMZVYBVAGJ-XEGUGMAKSA-N Tyr-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC1=CC=C(C=C1)O)N FNWGDMZVYBVAGJ-XEGUGMAKSA-N 0.000 description 1
- JKUZFODWJGEQAP-KBPBESRZSA-N Tyr-Gly-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N)O JKUZFODWJGEQAP-KBPBESRZSA-N 0.000 description 1
- AZGZDDNKFFUDEH-QWRGUYRKSA-N Tyr-Gly-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AZGZDDNKFFUDEH-QWRGUYRKSA-N 0.000 description 1
- HFJJDMOFTCQGEI-STECZYCISA-N Tyr-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N HFJJDMOFTCQGEI-STECZYCISA-N 0.000 description 1
- NSGZILIDHCIZAM-KKUMJFAQSA-N Tyr-Leu-Ser Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NSGZILIDHCIZAM-KKUMJFAQSA-N 0.000 description 1
- CDKZJGMPZHPAJC-ULQDDVLXSA-N Tyr-Leu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDKZJGMPZHPAJC-ULQDDVLXSA-N 0.000 description 1
- SINRIKQYQJRGDQ-MEYUZBJRSA-N Tyr-Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SINRIKQYQJRGDQ-MEYUZBJRSA-N 0.000 description 1
- AUZADXNWQMBZOO-JYJNAYRXSA-N Tyr-Pro-Arg Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CC=C(O)C=C1 AUZADXNWQMBZOO-JYJNAYRXSA-N 0.000 description 1
- XJPXTYLVMUZGNW-IHRRRGAJSA-N Tyr-Pro-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O XJPXTYLVMUZGNW-IHRRRGAJSA-N 0.000 description 1
- NZBSVMQZQMEUHI-WZLNRYEVSA-N Tyr-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NZBSVMQZQMEUHI-WZLNRYEVSA-N 0.000 description 1
- UUJHRSTVQCFDPA-UFYCRDLUSA-N Tyr-Tyr-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 UUJHRSTVQCFDPA-UFYCRDLUSA-N 0.000 description 1
- UDNYEPLJTRDMEJ-RCOVLWMOSA-N Val-Asn-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N UDNYEPLJTRDMEJ-RCOVLWMOSA-N 0.000 description 1
- LIQJSDDOULTANC-QSFUFRPTSA-N Val-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N LIQJSDDOULTANC-QSFUFRPTSA-N 0.000 description 1
- IQQYYFPCWKWUHW-YDHLFZDLSA-N Val-Asn-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N IQQYYFPCWKWUHW-YDHLFZDLSA-N 0.000 description 1
- HHSILIQTHXABKM-YDHLFZDLSA-N Val-Asp-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O HHSILIQTHXABKM-YDHLFZDLSA-N 0.000 description 1
- LMSBRIVOCYOKMU-NRPADANISA-N Val-Gln-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N LMSBRIVOCYOKMU-NRPADANISA-N 0.000 description 1
- QHFQQRKNGCXTHL-AUTRQRHGSA-N Val-Gln-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QHFQQRKNGCXTHL-AUTRQRHGSA-N 0.000 description 1
- VLDMQVZZWDOKQF-AUTRQRHGSA-N Val-Glu-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VLDMQVZZWDOKQF-AUTRQRHGSA-N 0.000 description 1
- XXROXFHCMVXETG-UWVGGRQHSA-N Val-Gly-Val Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXROXFHCMVXETG-UWVGGRQHSA-N 0.000 description 1
- HLBHFAWNMAQGNO-AVGNSLFASA-N Val-His-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCSC)C(=O)O)N HLBHFAWNMAQGNO-AVGNSLFASA-N 0.000 description 1
- SDUBQHUJJWQTEU-XUXIUFHCSA-N Val-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C(C)C)N SDUBQHUJJWQTEU-XUXIUFHCSA-N 0.000 description 1
- AEMPCGRFEZTWIF-IHRRRGAJSA-N Val-Leu-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O AEMPCGRFEZTWIF-IHRRRGAJSA-N 0.000 description 1
- ZHQWPWQNVRCXAX-XQQFMLRXSA-N Val-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZHQWPWQNVRCXAX-XQQFMLRXSA-N 0.000 description 1
- MLADEWAIYAPAAU-IHRRRGAJSA-N Val-Lys-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N MLADEWAIYAPAAU-IHRRRGAJSA-N 0.000 description 1
- HPANGHISDXDUQY-ULQDDVLXSA-N Val-Lys-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N HPANGHISDXDUQY-ULQDDVLXSA-N 0.000 description 1
- SVFRYKBZHUGKLP-QXEWZRGKSA-N Val-Met-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)O)N SVFRYKBZHUGKLP-QXEWZRGKSA-N 0.000 description 1
- OFQGGTGZTOTLGH-NHCYSSNCSA-N Val-Met-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N OFQGGTGZTOTLGH-NHCYSSNCSA-N 0.000 description 1
- NSUUANXHLKKHQB-BZSNNMDCSA-N Val-Pro-Trp Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CNC2=CC=CC=C12 NSUUANXHLKKHQB-BZSNNMDCSA-N 0.000 description 1
- UGFMVXRXULGLNO-XPUUQOCRSA-N Val-Ser-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O UGFMVXRXULGLNO-XPUUQOCRSA-N 0.000 description 1
- JAIZPWVHPQRYOU-ZJDVBMNYSA-N Val-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O JAIZPWVHPQRYOU-ZJDVBMNYSA-N 0.000 description 1
- ZNGPROMGGGFOAA-JYJNAYRXSA-N Val-Tyr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=C(O)C=C1 ZNGPROMGGGFOAA-JYJNAYRXSA-N 0.000 description 1
- 108010081404 acein-2 Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 108010066988 asparaginyl-alanyl-glycyl-alanine Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 108010081447 cytochrophin-4 Proteins 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 150000002256 galaktoses Chemical class 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 1
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 1
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010048994 glycyl-tyrosyl-alanine Proteins 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 210000002288 golgi apparatus Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000009643 growth defect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- LHVVWWADJUJFEH-HKNOZQPISA-N hexadecanoic acid (9Z,12Z)-octadeca-9,12-dienoic acid octadecanoic acid (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid (Z)-octadec-9-enoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCC\C=C/C\C=C/CCCCCCCC(O)=O.CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O LHVVWWADJUJFEH-HKNOZQPISA-N 0.000 description 1
- 108010085325 histidylproline Proteins 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 108010012988 lysyl-glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 238000007500 overflow downdraw method Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 101150079312 pgk1 gene Proteins 0.000 description 1
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108010004914 prolylarginine Proteins 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 230000012846 protein folding Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000012743 protein tagging Effects 0.000 description 1
- 230000007111 proteostasis Effects 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 108010054624 red fluorescent protein Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091000042 riboflavin kinase Proteins 0.000 description 1
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108010033670 threonyl-aspartyl-tyrosine Proteins 0.000 description 1
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000032895 transmembrane transport Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 108010071635 tyrosyl-prolyl-arginine Proteins 0.000 description 1
- 108010078580 tyrosylleucine Proteins 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 108010009962 valyltyrosine Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
- C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y121/00—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21)
- C12Y121/03—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21) with oxygen as acceptor (1.21.3)
- C12Y121/03008—Cannabidiolic acid synthase (1.21.3.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01006—Galactokinase (2.7.1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01026—Riboflavin kinase (2.7.1.26)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07002—FAD synthetase (2.7.7.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21048—Cerevisin (3.4.21.48)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/23—Aspartic endopeptidases (3.4.23)
- C12Y304/23005—Cathepsin D (3.4.23.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/23—Aspartic endopeptidases (3.4.23)
- C12Y304/23025—Saccharopepsin (3.4.23.25), i.e. yeast proteinase A
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开一种高产大麻二酚酸的酿酒酵母菌株构建方法和应用,属于合成生物学技术领域、基因工程领域。本发明以能够合成CBGA的酿酒酵母为出发菌株,选择性地敲除Pep4、Prb1、Mrs2、Der1,选择性地敲除Gal80并过表达Gal4,以及选择性地过表达Hac1、Fad1和Fmn1、Erv29,选择性地采用pGal1启动子表达CBDAS通过或不通过linker与不同标签蛋白(TrxA、MBP、DsRed.T3、GFP、mCherry)的融合蛋白,优化了CBDAS编码基因的表达水平和CBDAS的酶活水平,以提高CBDA的产量。
Description
技术领域
本发明涉及一种高产大麻二酚酸的酿酒酵母菌株构建方法和应用,属于合成生物学技术 领域、基因工程领域。
背景技术
许多大麻素以低含量存在,并且与其他相对更丰富的大麻素共存,使得难以从植物中获 得纯净的样品。类似地,化学合成大麻素及其衍生物的方法麻烦、昂贵,且产率低。因此, 需要制备纯大麻素、大麻素前体、大麻素衍生物或大麻素前体衍生物的另外的方法,例如生物合成法。
大麻素的生物合成方法利用了不同途径、不同物种的基因来生产大麻素类似物,此方法 为生产天然和非天然大麻素提供了一个平台,使大麻素的获取不再拘泥于传统的植物提取和 化学合成,也使科学家们对这些化合物进行更系统深入的研究,让大麻素更好得造福大众。
Luo et al.报道了酿酒酵母利用半乳糖完整合成了主要的大麻素:大麻萜酚酸(CBGA), Δ9-四氢大麻酸(THCA),大麻二酚酸(CBDA),Δ9-四氢大麻二酸(THCVA)和大麻二酸 (CBDVA)。Luo et al.的研究设计了天然甲羟戊酸途径以提供高通量的香叶基焦磷酸GPP, 并引入了异源的香叶基焦磷酸:橄榄油酸酯香叶基转移酶CsPT4基因,以GPP和橄榄酸OA 为底物合成得到了大麻素生物合成中的重要前体化合物:CBGA。在合成CBGA的途径中,通过半乳糖和OA的添加,可以实现CBGA的大量积累。
大麻二酚酸(CBDA)是由CBGA转化而来的。CBDA的从头生物合成途径如附图1所示,大麻二酚酸合成酶(CBDAS)将CBGA转化为CBDA,CBDA的脱羧得到大麻二酚(CBD)。 CBDA是一类重要的大麻素,与CBD一样,都可以激活5-HT1AA血清素受体,与调节情绪、 焦虑、失眠和恶心感有关,可用于药物、保健品及化妆品。
发明内容
[技术问题]
本发明要解决的技术问题是优化重组酿酒酵母的异源大麻二酚酸合成酶CBDAS的表达 水平,提高大麻二酚酸的产量。
[技术方案]
本发明提供了一种重组酿酒酵母,以表达合成大麻萜酚酸(CBGA)途径的酶、能够合 成CBGA的酵母为出发菌株,表达大麻二酚酸合成途径中的大麻二酚酸合成酶,部分内源性 基因被过表达或敲除,所述部分内源性基因包括:Fad1、Fmn1、Hac1、Pep4、Prb1、Mrs2、Gal80、Gal4、Erv29、Der1。进一步地,部分内源性基因被过表达或敲除是(a)~(k)任一 种:
(a)过表达Fad1、Fmn1,
(b)过表达Hac1,
(c)敲除Pep4,
(d)同时具有(a)、(b)、(c),
(e)在(d)的基础上,敲除Prb1,
(f)在(a)、(c)的基础上,敲除Mrs2、敲除Gal80、过表达Gal4,
(g)在(a)、(c)的基础上,敲除Mrs2、敲除Gal80、过表达Gal4、过表达Erv29,
(h)在(a)、(c)的基础上,敲除Der1,
(i)在(c)的基础上,敲除Gal80、过表达Gal4,
(j)在(a)、(c)的基础上,敲除Gal80、过表达Gal4,
(k)在(a)、(b)、(c)的基础上,敲除Gal80、过表达Gal4。
所述CBDAS基因编码大麻二酚酸合成酶,核苷酸序列可以是SEQ ID NO:1。所述CBDAS 的表达是指将异源的CBDAS基因插入到酿酒酵母基因组上去表达,可以通过内源性pGal1 启动子启动表达。
所述过表达是指把基因上调表达,即该基因被过度的转录、翻译,终基因表达产物超过 正常水平。
所述敲除是指令特定基因功能丧失。
所述大麻二酚酸合成酶(CBDAS)还可以通过或不通过linker与标签蛋白进行融合表达。 所述linker的序列可以如SEQ ID NO:2~SEQ ID NO:8任一所示。所述标签蛋白可以是TrxA (SEQ ID NO:9)、MBP(SEQ ID NO:10)、DsRed.T3(SEQ ID NO:11)、GFP(SEQ ID NO:12) 或mCherry(SEQ ID NO:13)。
所述Pep4基因编码空泡蛋白酶,核苷酸序列可以是NC_001148.4(259714..260931, complement)。所述敲除Pep4是指将酿酒酵母基因组上的Pep4不表达,可以通过缺失Pep4 的编码区来实现。
所述Gal80基因编码参与GAL基因抑制的转录调控因子,核苷酸序列可以是 NC_001145.3(171594..172901)。
所述Gal4基因编码参与GAL基因激活的转录调控因子,核苷酸序列可以是NC_001148.4 (79711..82356,complement)。所述敲除Gal80、过表达Gal4,是指将酿酒酵母基因组上Gal80 基因不表达同时强化Gal4的表达,可以通过缺失Gal80的编码区并在该位点使用优化的 pGal4mut启动子表达Gal4实现。
所述Fad1基因编码辅酶黄素腺嘌呤二核苷酸,核苷酸序列可以是NC_001136.10(372688..373608,complement)。
所述Fmn1基因编码辅酶黄素单核苷酸,核苷酸序列可以是NC_001136.10(935236..935892,complement)。所述过表达Fad1、Fmn1是指使用强启动子增加Fad1和Fmn1的表达量,可以通过内源性pPGK1(启动子序列是PGK1基因上游的600bp)和pTDH3启动 子实现(启动子序列是TDH3基因上游的600bp)。
所述Hac1基因编码转录激活因子,核苷酸序列可以是NC_001138.5(75179..76147)。所 述过表达Hac1是指使用强启动子增加Hac1的表达量,可以通过内源性pTDH3启动子替换 Hac1自身的pHac1启动子实现。
所述Prb1基因编码蛋白水解酶B,核苷酸序列可以是NC_001137.3(40046..41953,complement)。所述敲除Prb1是指将酿酒酵母基因组上的Prb1不表达,可以通过缺失Prb1的编码区来实现。
所述Der1基因编码用于促进错误折叠多肽输出到细胞质的内质网膜蛋白,核苷酸序列可 以是NC_001134.8(623576..624211)。所述敲除Der1是指将酿酒酵母基因组上的Der1不表达, 可以通过缺失Der1的编码区来实现。
所述Mrs2基因编码线粒体镁离子转运蛋白,核苷酸序列可以是NC_001147.6(944596..946008)。所述敲除Mrs2是指将酿酒酵母基因组上的Mrs2不表达,可以通过缺失Mrs2的编码区来实现。
所述Erv29基因编码COPII包被的内质网衍生的转运囊泡的成分,核苷酸序列可以是 NC_001139.9(1060658..1061590,complement)。所述过表达Erv29是指使用强启动子增加Erv29的表达量,可以通过内源性pTEF1启动子替换Erv29自身的pErv29启动子实现。
本发明还提供了构建所述重组酿酒酵母的方法,包括以下步骤:
(1)PCR扩增得到需要过表达的基因的表达盒,整合到酿酒酵母基因组上;或者,PCR 扩增得到用于敲除基因的同源片段,用同源片段替换酿酒酵母基因组上的待敲除基因;
使用CRISPR-Cas9技术实现酿酒酵母基因组上的基因敲除和插入;
(2)筛选获得阳性克隆。
本发明提供了促进酿酒酵母产大麻二酚酸的产量的方法,是:
(1)对表达大麻二酚酸合成酶能够合成CBDA的重组酵母采用权利要求2中(a)~(k) 任一所述的改造,或者,
(2)将大麻二酚酸合成酶利用或不利用linker与标签蛋白进行融合表达,所述标签蛋白 是TrxA、MBP、DsRed.T3、GFP或mCherry,或者,
(3)组合使用(1)、(2)。
本发明还提供了所述重组酿酒酵母在生产大麻二酚酸中的应用,包括以下步骤:
(1)活化培养重组酿酒酵母,并培养得到重组酿酒酵母种子液,
(2)将重组酿酒酵母种子液转接到合适产大麻二酚的培养基中,在适宜条件下培养重组 酿酒酵母使之产大麻二酚酸。
本发明所述重组酿酒酵母还可以用于生产大麻二酚,具体地,在本发明重组酿酒酵母中 表达脱羧酶,将大麻二酚酸脱羧得到大麻二酚,或者,将本发明重组酿酒酵母生产得到的大 麻二酚酸进行分离提纯,然后在体外利用酶催化剂或者化学催化剂进行脱羧得到大麻二酚。
[有益效果]
本发明以能够合成CBGA的酿酒酵母为出发菌株,选择性地敲除Pep4、Prb1、Mrs2、Der1,选择性地敲除Gal80并过表达Gal4,以及选择性地过表达Hac1、Fad1和Fmn1、Erv29,选择性地采用pGal1启动子表达CBDAS通过或不通过linker与不同标签蛋白(TrxA、MBP、DsRed.T3、GFP、mCherry)的融合蛋白,优化了CBDAS编码基因的表达水平和CBDAS的酶 活水平,以提高CBDA的产量。
附图说明
图1为大麻二酚酸在酿酒酵母中的合成途径;
图2为在产CBDA菌株ySC012的基础上,敲除空泡蛋白酶Pep4、过表达辅酶黄素腺嘌呤二核苷酸酶Fad1和黄素单核苷酸酶Fmn1、过表达转录激活因子Hac1、以及敲除蛋白酶Prb1对于CBDA产率的影响。从图中可以看出,这些改造可以促进CBDA的积累。其中, 敲除空泡蛋白酶Pep4、过表达辅酶黄素腺嘌呤二核苷酸酶Fad1和黄素单核苷酸酶Fmn1、过 表达转录激活因子Hac1这三类酶改造的叠加可以有效提高CBDA的积累。
图3为在产CBDA菌株ySC242的基础上,过表达辅酶黄素腺嘌呤二核苷酸酶Fad1和黄 素单核苷酸酶Fmn1、敲除Gal80过表达Gal4、敲除Mrs2、敲除Der1、以及过表达Erv29对于CBDA产率的影响。从图中可以看出,过表达辅酶黄素腺嘌呤二核苷酸酶Fad1和黄素单 核苷酸酶Fmn1、敲除Gal80过表达Gal4,这些改造后CBDA的积累明显提高。同时,ySC220 与ySC242的CBDA产量对比显示,CBDAS与蛋白的融合表达可以明显提高CBDA的积累。
图4为不同蛋白(TrxA、MBP、DsRed.T3、GFP、mCherry)与CBDAS融合表达菌株的 大麻二酚酸CBDA产率比较。在调控4类酶(转录激活因子Hac1、空泡蛋白酶Pep4、辅酶黄素腺嘌呤二核苷酸Fad1和黄素单核苷酸Fmn1、敲除Gal80过表达Gal4)的表达的基础上, TrxA、MBP、DsRed.T3、GFP、mCherry与CBDAS的融合表达都能实现CBDA的积累。
图5为不同linker融合表达DsRed.T3和CBDAS菌株的大麻二酚酸CBDA产率比较。在调控4类酶(转录激活因子Hac1、空泡蛋白酶Pep4、辅酶黄素腺嘌呤二核苷酸Fad1和黄素 单核苷酸Fmn1、敲除Gal80过表达Gal4)的表达的基础上,使用不同linker融合表达DsRed.T3和CBDAS的系列菌株,都实现了CBDA的生产。
具体实施方式
为使本发明的上述目的、特征和优点能够更加浅显易懂,下面本发明的具体实施方式做 详细的说明。在下面的描述中阐述了很多具体细节以便于充分理解本发明。但是本发明能够 以很多不同于在此描述的其它方式来实施,本领域技术人员可以在不违背本发明内涵的情况下做类似改进,因此本发明不受下面公开的具体实施例的限制。
术语:
CBDAS是指,异源大麻二酚酸合成酶。
Pep4编码空泡蛋白酶,即蛋白酶A,可以激活其它一些蛋白酶的活性。
Fad1编码黄素腺嘌呤二核苷酸合成酶,能够用于合成黄素腺嘌呤二核苷酸(FAD)。
Fmn1编码核黄素激酶,能够用于合成黄素核苷酸(FMN)。
Prb1编码蛋白水解酶B,具有H3N端内肽酶活性。细胞内蛋白水解酶B的缺失可以保护表达产物免受降解,促进表达量的提高。
Der1编码用于促进错误折叠多肽输出到细胞质的内质网膜蛋白。内质网是蛋白质合成和 折叠的重要场所,在内质网中的蛋白质稳态由一套精细的质量控制系统调控。当新合成的蛋 白质发生错误折叠时,它最终会被从内质网中逆向转运到细胞质,随后被多泛素化并降解,这是一种称为内质网相关蛋白降解(ERAD)的途径。在此过程中,负责跨膜运输的蛋白质 通道由Der1和Hrd1这两个“半通道”组成。这两个“半通道”的共同作用,可以降低两侧 都亲水的多肽环跨膜所遇到的能阻。
Mrs2编码线粒体镁离子转运蛋白,MRS2缺失会导致酵母线粒体镁离子浓度下降、线粒 体内域型内含子剪接缺陷和非发酵碳源培养基上的生长缺陷。
Erv29编码COPII包被的内质网衍生的转运囊泡的成分。用于将一部分分泌蛋白有效运 输到高尔基体。
pGal1是启动子,是编码半乳糖激酶的Gal1基因上游的600bp部分,Gal1基因的核苷酸序 列是NC_001134.8(279021..280607)。
Gal80是参与抑制Gal基因的转录调节因子,Gal4受Gal80抑制。
Gal4编码转录激活蛋白GAL4,GAL4能识别基因启动子的上游激活序列(UASg)的17bp 长的一段序列:5'-CGGRNNRCYNYNYNCNCCG-3'(R表示嘌呤,Y表示嘧啶,N表示任意 脱氧核苷酸)。GAL4与GAL80作用,GAL80可结合半乳糖代谢产物。【GAL4/UAS是存 在于酵母中的基因表达调控系统。UAS是upstream activating sequence的缩写。GAL4是转录 调控因子,其Binding domain(BD)与UAS序列结合后,其Activity domain(AD)和promoter 区域结合,从而诱导基因的表达。GAL4/UAS系统已广泛应用于各种基因调控研究中。】
TrxA:硫氧还蛋白A。
MBP:麦芽糖结合蛋白。
DsRed.T3是一种红色荧光蛋白,来源于Discosoma sp.。
GFP:绿色荧光蛋白。
mCherry:一种红色荧光染料。
实验方法:
过表达,是指把基因上调表达,即该基因被过度的转录、翻译,终基因表达产物超过正 常水平。
敲除,是用含有一定已知序列的DNA片段与受体细胞基因组中序列相同或相近的基因 发生同源重组,令受体细胞基因组中特定的基因功能丧失作用。
下述实施例所用的PCR扩增方法、不同片段的融合方法、基因敲除及过表达方法可以采 用本领域常见的技术手段,例如融合PCR、同源重组、CRISPR-Cas9技术。所用的酶、试剂盒均是可以购买的已经商业化的产品。
转化,是采用醋酸锂/PEG3350。下述实施例采用的转化方法是:先将宿主菌株在1×YPD 培养基中活化,30℃,200rpm培养过夜。然后接种到新的2×YPD培养基中使起始OD值为 0.2,30℃继续培养4-4.5h后,取5OD菌液,常温3000rcf,离心5min,弃上清,并用灭菌 超纯水洗涤两次,获得酵母细胞;配制DNA混合物,每个构建取5OD的菌液获得细胞,并 与50μLDNA混合物混合,使细胞重悬,50μL DNA混合物由2μg所述插入片段、250ng工 具质粒以及足量ddH2O混合而成。在悬浮的细胞中加入醋酸锂转化混合物,经培养后获取细 胞,涂布到筛选平板上,获取单菌落,即为重组酿酒酵母,测序验证转化成功后,将重组酿 酒酵母进行保存。
菌落PCR及测序验证:待筛选平板上长出单克隆菌落后,进行菌落PCR及测序验证,具体步骤是:用枪头挑取少量细胞分别置于20μL 20mmol/L NaOH溶液,涡旋混匀,于金属浴95℃孵育20min,涡旋混匀,取1μL菌液作为模板进行菌落PCR反应,反应引物为引物7 和引物8,比对克隆条带与阴性克隆条带大小,挑选菌落PCR阳性克隆的菌液送致金唯智公 司进行测序验证。测序正确的菌株进行划线保存和甘油冻存。
重组酿酒酵母菌株的培养:单菌落在3ml 1×YPD 24孔板30℃200rpm摇床中过夜培养 16h后,过夜菌液用1×YPD稀释10倍后用紫外分光光度计检测菌液OD,波长设置为600nm。 然后使起始OD为0.2转接至3mL 1×YPG培养液中培养。培养方式为:转接后,每隔24h 添加10μL 0.1M OA,300μL 20%半乳糖。培养72h后收集200μL菌液为样品。
重组酿酒酵母产CBDA的量的检测方法:样品收集后,根据样品OD600,先用破壁酶2U/OD于30℃,200rpm摇床温育处理60min,然后加入0.2mL体积0.5mm玻璃珠和0.4ml 的乙酸乙酯:甲酸(0.05%),在高速组织研磨仪中,以65Hz处理180s,间隔30s,重复三次,每次处理后将研磨托盘置于冰上冷却1min,震荡15-30s,瞬时离心后,取上层有机层 0.28mL至1.5mL离心管中,重复两次,并将收集的上层有机相合并。三次提取的有机层,Evaporation,mode V-AL,45℃1h挥干至无溶剂残留,用重悬液AHF(乙腈:H2O:甲酸 =80:20:0.05%,含内标PHB(对羟基苯甲酸丙酯溶液标准物质,15μM)140μL重悬,0.22μm PVDF滤膜过滤至液相检测瓶内插管中,作为检测样品。每种样品三个平行。样品准备好之后,用HPLC进行检测,检测条件见表1。
表1:HPLC检测条件
2×YPD培养基配方:酵母浸膏20.0g/L,蛋白胨40.0g/L,葡萄糖40.0g/L。
醋酸锂转化混合物:50%W/V PEG3350 260μL,1mol/L LiOAc 36μL,变性鲑鱼精DNA 10μL(变性鲑鱼精DNA使用前先置于95℃金属浴变性5min),ddH2O 4μL。
缺少尿嘧啶的筛选平板配方:酵母氮源母液1.7g/L,硫酸铵5g/L,各种氨基酸如表1所 示,琼脂20g/L,葡萄糖20g/L,注:葡萄糖分开灭菌。
表2筛选平板中各种氨基酸的含量
下述实施例所用的菌株yCAN31的基因信息如下表3所示。
表3 yCAN31的基因信息
实施例1构建表达大麻二酚酸合成途径的酿酒酵母ySC012
通过2×Phanta Max Master Mix(Phanta DNA聚合酶)进行PCR扩增整合片段。以酿酒 酵母CEN.PK2-1C的基因组为模板,使用表3中的引物1和引物2扩增获得整合位点上游同 源臂416d-Up片段,使用引物3和引物4扩增获得整合位点下游同源臂416d-Down片段;以酿酒酵母CEN.PK2-1C的基因组为模板,通过PCR扩增得到启动子pGal1、终止子tADH1 的片段,以合成的CBDAS基因(SEQ ID NO:1)为模板,通过PCR扩增得到416d-Up -pGal1-CBDAS-tADH1-416d-Down表达盒片段。然后将416d-Up -pGal1-CBDAS-tADH1-416d-Down表达盒片段转化到宿主酿酒酵母yCAN31(Luo et al.报道的 产CBGA菌株)中,获得菌株ySC012。表4中的引物5和引物6用于对菌株ySC012进行PCR 反应,获得菌落PCR阳性克隆的菌液,用于基因测序。
培养ySC012,并检测CBDA的含量,如图2所示,出发菌株yCAN31不产CBDA,而 表达了CBDAS的重组菌株ySC012的CBDA的含量为9.72μM。
表4构造CBDAS表达菌株引物序列
引物序号 | 碱基序列 | |
1 | GTCGTGGCAAGAATACCAA | SEQ ID NO:14 |
2 | GGCCAGGTTACTGCCAAT | SEQ ID NO:15 |
3 | GCGAATTTCTTATGATTTATG | SEQ ID NO:16 |
4 | ATTTTTCAATTGAGGAAACTTGAAAGGTGT | SEQ ID NO:17 |
5 | TGGCTTTTTGATTGATTGTACAGGA | SEQ ID NO:18 |
6 | TCGCAATAATCTATATGCTCACCAA | SEQ ID NO:19 |
实施例2在产大麻二酚酸菌株ySC012基因组中过表达辅酶黄素腺嘌呤二核苷酸Fad1 基因和黄素单核苷酸Fmn1基因,构建Fad1和Fmn1过表达菌株ySC044
以酿酒酵母ySC012的基因组为模板,通过2×Phanta Max Master Mix(PhantaDNA聚合 酶),使用表5的引物1和引物2扩增获得整合的整合位点上游同源臂与Fad1基因表达盒 Up-Fad1片段,使用表5的引物3和引物4扩增获得整合的整合位点下游同源臂与Fmn1基因 表达盒Fmn1-Down片段。进行PCR扩增来整合片段。然后将整合的片段转化到宿主酿酒酵母ySC012中,获得菌株ySC044。表5的引物5和引物6用于对菌株ySC044进行PCR反应, 获得菌落PCR阳性克隆的菌液,用于基因测序。
培养ySC044,并检测CBDA的含量,如图2所示,ySC044的CBDA的含量为28.15μM。
表5过表达FAD1和FMN1引物序列
引物序号 | 碱基序列 | |
1 | TTTGCACATAAAGGGTGCCTTCA | SEQ ID NO:20 |
2 | AAAGTGCCCTCGGCAAAAG | SEQ ID NO:21 |
3 | GTACGGTTTAACGGAGG | SEQ ID NO:22 |
4 | AAACCAATAACTTATAACAACATAGCGGC | SEQ ID NO:23 |
5 | CGACGGCTATAAAAGGAAGTTTTCC | SEQ ID NO:24 |
6 | GAAGCCAAAGCAGCAATAGCAG | SEQ ID NO:25 |
实施例3在产大麻二酚酸菌株ySC012基因组中敲除空泡蛋白酶Pep4基因,得到重组 酿酒酵母ySC207
通过2xPhanta Max Master Mix(Phanta DNA聚合酶)进行PCR扩增整合片段。以酿酒 酵母ySC012基因组为模板,使用表6中的引物1和引物2扩增获得上游同源臂Pep4-Up片段,使用表6中的引物3和引物4扩增获得下游同源臂Pep4-Down片段。然后将片段的组合 转化到宿主酿酒酵母ySC012中,获得菌株ySC207。表6中的引物1和引物4用于对菌株 ySC207进行PCR反应,获得菌落PCR阳性克隆的菌液,用于基因测序。
培养ySC207,并检测CBDA的含量,如图2所示,ySC207中的CBDA的含量为14.42μM。
表6敲除Pep4引物序列
引物序号 | 碱基序列 | |
1 | CCTTGAAGTTTTGAGGTGGAGTA | SEQ ID NO:26 |
2 | TCCGAAACTAGGCAGCGTAAACACGAGTTGTCCGATGA | SEQ ID NO:27 |
3 | CGCTGCCTAGTTTCGGATCAAGCTGAACATGTTAGTTTTGG | SEQ ID NO:28 |
4 | CTGCTATTTATTCATTCCACCTTCT | SEQ ID NO:29 |
实施例4在产大麻二酚酸菌株ySC012基因组中采用pTDH3启动子过表达转录激活因 子HAC1以构建ySC220
替换Hac1启动子,构建菌株ySC220。通过2×Phanta Max Master Mix(Phanta DNA聚 合酶)进行PCR扩增整合片段。以酿酒酵母ySC012基因组为模板,使用表7的引物1和引物2扩增获得上游同源臂Hac1s-Up片段,使用表7的引物3/4及5/6融合扩增获得下游同源 臂Hac1s-Down片段。使用表7的引物7和引物8扩增出片段pTDH3。然后将片段的组合 pTDH3-Hac1s-tHac1转化到宿主酿酒酵母ySC012中,获得菌株ySC220。表7的引物1和引物6用于对重组酿酒酵母进行PCR反应,获得菌落PCR阳性克隆的菌液,用于基因测序。 验证正确后,菌株ySC220构建成功,作为替换Hac1启动子的宿主菌。
培养ySC220,并检测CBDA的含量,如图2所示,ySC220中的CBDA的含量为15.96μM。
表7替换Hac1启动子引物序列
实施例5在重组酿酒酵母ySC220基因组中敲除Pep4以构建ySC221
将实施例3中的Pep4-Up、Pep4-Down作为插入片段转化至酿酒酵母ySC220中,获得敲 除Pep4基因的重组酿酒酵母ySC221。
培养ySC221,并检测CBDA的含量,如图2所示,ySC221中的CBDA的含量为34.26μM。
实施例6在重组酿酒酵母ySC221基因组中过表达Fad1和Fmn1以构建ySC222
将实施例2中的Up-Fad1、Fmn1-Down作为插入片段转化至酿酒酵母ySC221中,获得调控Fad1和Fmn1表达水平的重组酿酒酵母ySC222。
培养ySC222,并检测CBDA的含量,如图2所示,ySC222中的CBDA的含量为53.26μM。
实施例7在重组酿酒酵母ySC222基因组中敲除Prb1以构建ySC223
通过2×Phanta Max Master Mix(Phanta DNA聚合酶)进行PCR扩增整合片段。以初始 酿酒酵母ySC222基因组为模板,使用表8的引物1和引物2扩增获得上游同源臂Prb1-Up 片段,使用表8的引物3和引物4扩增获得下游同源臂Prb1-Down片段。然后将片段的组合转化到宿主酿酒酵母ySC222中,获得菌株ySC223。表8的引物1和引物4用于对菌株ySC223进行PCR反应,获得菌落PCR阳性克隆的菌液,用于基因测序。
培养ySC223,并检测CBDA的含量,如图2所示,ySC223中的CBDA的含量为43.57μM。
表8敲除Prb1引物序列
实施例8重组菌株ySC242的构建
将实施例4中的Hac1s-Up、Hac1s-Down和pTDH3片段,以及实施例1中的416d-Up片段、416d-Down片段和pGal1-mCherry-CBDAS-tADH1表达盒片段(以ySC012的基因组和合 成的mCherry基因为模板扩增)作为插入片段转化至yCAN31中,获得ySC242。
培养ySC242,并检测CBDA的含量,如图3所示,ySC242中的CBDA的含量为67.77μM,是ySC220(15.96μM)产量的4.2倍。
实施例9在产大麻二酚酸菌株ySC242基因组中敲除Gal80并过表达Gal4
通过2×Phanta Max Master Mix(Phanta DNA聚合酶)进行PCR扩增整合片段。以初始 酿酒酵母ySC012的基因组为模板,使用表9的引物1和引物2扩增获得上游同源臂Gal80-Up 片段,使用表9的引物3和引物4扩增获得下游同源臂Gal80-Down片段;以经过序列优化 的Gal4质粒为模板,使用表9的引物5和引物6通过PCR扩增得到Gal4表达盒片段。然后将片段的组合转化到宿主酿酒酵母ySC242中,获得菌株ySC257。表9的引物7和引物8用于对菌株ySC257进行PCR反应,获得菌落PCR阳性克隆的菌液,用于基因测序。
培养ySC257,并检测CBDA的含量,如图3所示,ySC257中的CBDA的含量为94.33μM。
表9改造Gal80引物序列
引物序号 | 碱基序列 | |
1 | AAGACGGGTCGGATACCTG | SEQ ID NO:42 |
2 | CAATAGAGCACCTGGCAGTCATCTCGACGGGAGTGGAAAGAACG | SEQ ID NO:43 |
3 | CTCAGGTATAGCATGAGGTCGCTCTAAGCATCTTGCCCTGTG | SEQ ID NO:44 |
4 | GGCTAGATTATTCTCAGGA | SEQ ID NO:45 |
5 | GTTTCCCGTTCTTTCCACTCCCGTCGAGATGACTGCCAGGTGCT | SEQ ID NO:46 |
6 | GGGCCAAGCACAGGGCAAGATGCTTAGAGCGACCTCATGCTATACC | SEQ ID NO:47 |
7 | TGTCTGCTACATTCATAATAACCA | SEQ ID NO:48 |
8 | TTTGACAGTTATACGTAGCAT | SEQ ID NO:49 |
实施例10在产大麻二酚酸菌株ySC242基因组中过表达Fad1和Fmn1以构建重组菌株 ySC287
将实施例2中的Up-Fad1、Fmn1-Down作为插入片段转化至酿酒酵母ySC242中,获得调控Fad1和Fmn1表达水平的重组酿酒酵母ySC287。
培养ySC287,并检测CBDA的含量,如图3所示,ySC287中的CBDA的含量为77.99μM。
实施例11重组菌株ySC342的构建
将实施例9中的Gal80-Up、Gal80-Down和Gal4表达盒片段作为插入片段转化至酿酒酵 母ySC287中,获得重组酿酒酵母ySC342。
培养ySC342,并检测CBDA的含量,如图3所示,ySC342中的CBDA的含量为38.43μM。
实施例12在产大麻二酚酸菌株ySC342基因组中敲除Der1构建重组菌株ySC349
通过2xPhanta Max Master Mix(Phanta DNA聚合酶)进行PCR扩增整合片段。以初始 酿酒酵母ySC012基因组为模板,使用表10的引物1和引物2扩增获得上游同源臂Der1-Up片段,使用表10的引物3和引物4扩增获得下游同源臂Der1-Down片段。然后将片段的组 合转化到宿主酿酒酵母ySC342中,获得菌株ySC349。表10的引物1和引物4用于对菌株 ySC302进行PCR反应,获得菌落PCR阳性克隆的菌液,用于基因测序。
培养ySC349,并检测CBDA的含量,如图3所示,ySC349中的CBDA的含量为30.42μM。
表10敲除Der1引物序列
实施例13在产大麻二酚酸菌株ySC342基因组中敲除Mrs2构建重组菌株ySC357
通过2xPhanta Max Master Mix(Phanta DNA聚合酶)进行PCR扩增整合片段。以初始 酿酒酵母ySC012基因组为模板,使用表11的引物1和引物2扩增获得上游同源臂Mrs2-Up片段,使用表11的引物3和引物4扩增获得下游同源臂Mrs2-Down片段。然后将片段的组 合转化到宿主酿酒酵母ySC342中,获得菌株ySC357。表11的引物1和引物4用于对菌株 ySC357进行PCR反应,获得菌落PCR阳性克隆的菌液,用于基因测序。
培养ySC284,并检测CBDA的含量,如图3所示,ySC357中的CBDA的含量为40.01μM。
表11敲除Mrs2引物序列
实施例14在敲除Mrs2的基础上过表达Erv29
通过2xPhanta Max Master Mix(Phanta DNA聚合酶)进行PCR扩增整合片段。以初始 酿酒酵母ySC357的基因组为模板,使用表12的引物1和引物2扩增获得上游同源臂Mrs2-Up 片段,使用表12的引物3和引物4扩增获得下游同源臂Mrs2-Down片段;以ySC357的基因组为模板,使用表12的引物5和引物6通过PCR扩增得到Erv29表达盒片段。然后将片段 的组合转化到宿主酿酒酵母ySC357中,获得菌株ySC359。表12的引物7和引物8用于对 菌株ySC359进行PCR反应,获得菌落PCR阳性克隆的菌液,用于基因测序。
培养ySC359,并检测CBDA的含量,如图3所示,ySC359中的CBDA的含量为34.46μM。
表12改造Erv29引物序列
引物序号 | 碱基序列 | |
1 | GATACAGCATGTCCTCCGCTATT | SEQ ID NO:58 |
2 | CTTAATATACATGGGACGAAAAGCGGATAATAGTACGCCGATTCATGAG | SEQ ID NO:59 |
3 | ATCGCACAGAATTCCCTTGTATTATAGGACAGTCAATAGCGGTTGGGAG | SEQ ID NO:60 |
4 | AGTTTGCTGCTGATTTGGATGC | SEQ ID NO:61 |
5 | CATCTCATGAATCGGCGTACTATTATCCGCTTTTCGTCCCATGTAT | SEQ ID NO:62 |
6 | CACTCCCAACCGCTATTGACTGTCCTATAATACAAGGGAATTCTGTG | SEQ ID NO:63 |
7 | GCATTGCCCGCCATCAG | SEQ ID NO:64 |
8 | TTTCCAAATCATATCTCTGTTCTGC | SEQ ID NO:65 |
实施例15构造酿酒酵母ySC340
ySC340:过表达转录激活因子Hac1基因、敲除空泡蛋白酶Pep4基因、过表达辅酶黄素 腺嘌呤二核苷酸Fad1基因和黄素单核苷酸Fmn1基因、以及敲除Gal80基因并在该位点过表 达Gal4基因。
将实施例2中的Up-Fad1、Fmn1-Down片段,实施例3中的Pep4-Up、Pep4-Down片段,实施例4中的Hac1s-Up、Hac1s-Down(pTDH3)和pTDH3片段,实施例9中的Gal80-Up、 Gal80-Down和Gal4表达盒片段转化至yCAN31中,获得优化酿酒酵母内源性基因表达的重组菌株ySC340。
培养ySC340(未表达CBDAS基因),并检测CBDA的含量,结果表明,没有表达CBDAS基因,ySC340中的CBDA的含量为0μM。
实施例16在完成以上各类酶的改造的基础上构造不同蛋白 (TrxA/MBP/DsRed.T3/GFP/mCherry)与CBDAS融合表达菌株
通过2×Phanta Max Master Mix(Phanta DNA聚合酶)进行PCR扩增整合片段。以酿酒 酵母ySC012的基因组为模板,使用表13的引物1和引物2扩增获得上游同源臂416d-Up片 段,使用表13的引物3和引物4扩增获得下游同源臂416d-Down片段;以酿酒酵母ySC012的基因组和合成的TrxA、MBP、DsRed.T3、GFP、mCherry基因为模板,通过PCR扩增得到 不同蛋白(TrxA/MBP/DsRed.T3/GFP/mCherry)-CBDAS表达盒片段(TrxA-CBDAS、 MBP-CBDAS、DsRed.T3-CBDAS、GFP-CBDAS、mCherry-CBDAS)。然后将片段的组合转 化到宿主酿酒酵母ySC340中,获得系列菌株ySC344、ySC345、ySC346、ySC347、ySC348。 表13的引物5和引物6用于对系列菌株ySC344-348进行PCR反应,获得菌落PCR阳性克 隆的菌液,用于基因测序。
经检测,如图4所示,ySC344、ySC345、ySC346、ySC347、ySC348中的CBDA的含量 分别为39.83、19.66、77.40、52.98、51.77μM。
表13构造不同蛋白融合CBDAS引物序列
实施例17在完成以上各类酶的改造的基础上利用linker构造DsRed.T3-CBDAS菌株
通过2×Phanta Max Master Mix(Phanta DNA聚合酶)进行PCR扩增整合片段。
以酿酒酵母ySC012的基因组为模板,通过PCR扩增得到上游同源臂416d-Up片段;
以酿酒酵母ySC012的基因组为模板,通过PCR扩增得到下游同源臂416d-Down片段;
以酿酒酵母ySC346的基因组为模板,通过PCR扩增得到不同linker连接的DsRed.T3-CBDAS表达盒片段;
将416d-Up、不同linker连接的DsRed.T3-CBDAS表达盒片段、416d-Down作为插入片 段转化至酿酒酵母ySC340中,获得调控CBDAS表达水平的系列重组酿酒酵母ySC366、ySC384、ySC385、ySC386、ySC387、ySC388、ySC389。
表14的引物5和引物6用于对系列菌株ySC366、ySC384-389进行PCR反应,获得菌落PCR阳性克隆的菌液,用于基因测序。
表14构造DsRed.T3-CBDAS引物序列
引物序号 | 碱基序列 | |
1 | GTCGTGGCAAGAATACCAA | SEQ ID NO:72 |
2 | GGCCAGGTTACTGCCAAT | SEQ ID NO:73 |
3 | GCGAATTTCTTATGATTTATG | SEQ ID NO:74 |
4 | ATTTTTCAATTGAGGAAACTTGAAAGGTGT | SEQ ID NO:75 |
5 | TGGCTTTTTGATTGATTGTACAGGA | SEQ ID NO:76 |
6 | TCGCAATAATCTATATGCTCACCAA | SEQ ID NO:77 |
如图5所示,ySC346、ySC366、ySC 384、ySC385、ySC386、ySC 387、ySC 388、ySC389、 中的CBDA的含量分别为77.40、136.72、70.34、52.55、59.53、69.48、59.80、49.98μM。
表15为菌株构建信息
综上所述,结合图2-5可以看出,本发明通过调控酵母细胞内源转录激活因子Hac1、空 泡蛋白酶Pep4、辅酶黄素腺嘌呤二核苷酸Fad1和黄素单核苷酸Fmn1、Gal80与Gal4蛋白的 表达,达到优化CBDAS表达的效果。改造后的工程菌株可以合理地在整个合成通路中利用 中间产物CBGA生成目标产物CBDA,实现了大麻素前体大麻萜酚酸CBGA向大麻二酚酸 CBDA的转化。本发明通过在酵母中通过调控各类酶的表达,改善CBGA的积累以及其向CBDA的转化,对CBDA的生物合成具有十分重要的意义。
实施例18实施例1-17构建的重组酿酒酵母在生产大麻二酚中的应用
在实施例1-17构建的重组酿酒酵母中进一步表达脱羧酶,使大麻二酚酸脱羧得到大麻二 酚。或者,将利用实施例1-17构建的重组酿酒酵母生产得到的大麻二酚酸经过热处理脱羧得 到大麻二酚。
SEQUENCE LISTING
<110> 森瑞斯生物科技(深圳)有限公司
<120> 一种高产大麻二酚酸的酿酒酵母菌株构建方法和应用
<130> IBAA211538A
<160> 77
<170> PatentIn version 3.3
<210> 1
<211> 1635
<212> DNA
<213> 人工序列
<400> 1
atgaactgtt ccgcattctc tttttggttt gtctgtaaaa tcatcttttt cttcttgagc 60
tttaacattc aaatcagtat cgctaatcca agagaaaatt tcttgaagtg tttttctcag 120
tatatcccga ataatgcgac gaaccttaag ttagtataca ctcagaacaa ccctctatat 180
atgagcgttc taaattctac aatccacaac ctaagattta cgtccgacac gactccgaaa 240
cccctagtta tagtgacacc gtcacatgtt agccatatac agggcaccat actatgttcc 300
aaaaaagttg ggttacaaat acgtacccgt agcgggggac acgacagtga ggggatgagt 360
tatattagtc aggtgccttt cgtcatagtg gatttaagaa atatgaggtc aattaaaatc 420
gacgttcact cacaaactgc ctgggttgag gcgggggcca cattgggtga agtatattac 480
tgggtcaatg agaagaacga gaatctttca ctagcagccg gttattgtcc cacagtctgc 540
gccggcggtc actttggcgg cggcggatac ggtcccttaa tgagaaatta cgggcttgcc 600
gcagacaata tcatagatgc tcacttagtt aatgttcatg gaaaagtgtt agaccgtaaa 660
agcatggggg aggatctgtt ttgggcgctt agagggggag gggcagaatc atttggaata 720
atagtggcat ggaaaatcag gcttgtggct gttccaaaga gtaccatgtt ctcagtaaag 780
aaaataatgg agatccatga gctagttaaa cttgtgaata aatggcaaaa catagcctat 840
aaatatgata aggacttgct gcttatgact catttcataa ccagaaacat tacggataac 900
caagggaaga acaaaacagc catccatacc tactttagct ccgttttctt gggtggtgta 960
gacagcttag ttgacctgat gaacaagagt tttccggaac taggtatcaa gaagacagat 1020
tgtagacaac tttcctggat tgataccata atcttttaca gcggagtcgt caattatgac 1080
actgacaact tcaacaagga aattttatta gataggagtg cgggtcaaaa tggggccttc 1140
aagatcaaac tagactacgt taaaaaaccc attcctgaaa gtgtttttgt tcagattctg 1200
gagaagctgt atgaagaaga tattggcgcg gggatgtacg ctctttatcc gtacggcggc 1260
ataatggatg agattagtga aagcgccatc cctttccccc acagagctgg tatcctgtac 1320
gagttgtggt atatctgctc ctgggagaaa caggaggata acgaaaagca cttaaattgg 1380
attaggaata tctacaattt catgacgccc tacgtttcca agaaccccag gttggcctat 1440
ttgaactaca gggatcttga tattggaatc aacgacccca aaaacccaaa caactacacc 1500
caggcaagga tttggggaga gaagtacttc gggaagaact tcgacaggct agttaaggtg 1560
aaaacgctag ttgatccaaa taattttttc agaaacgaac agagtatccc tcccttaccg 1620
cgtcataggc actaa 1635
<210> 2
<211> 27
<212> DNA
<213> 人工序列
<400> 2
tctggtggag gcggtggagg ctctaga 27
<210> 3
<211> 45
<212> DNA
<213> 人工序列
<400> 3
ggtggcggtg gctcgggcgg tggtgggtcg ggtggcggtg gctcg 45
<210> 4
<211> 36
<212> DNA
<213> 人工序列
<400> 4
ggttctgctg gatctgctgc cggttctgga gaattt 36
<210> 5
<211> 21
<212> DNA
<213> 人工序列
<400> 5
ggatccggtt ctggtggatc c 21
<210> 6
<211> 39
<212> DNA
<213> 人工序列
<400> 6
tcttctggag gtagcggtgg ttccggaggt tcggctggc 39
<210> 7
<211> 45
<212> DNA
<213> 人工序列
<400> 7
gaagccgctg caaaagaagc tgccgcaaaa gaggcggcag ctaag 45
<210> 8
<211> 138
<212> DNA
<213> 人工序列
<400> 8
gcagaagccg cggcaaaaga ggcagctgct aaagaggctg cagccaaaga agctgccgcc 60
aaagcattgg aagcagaagc agctgcaaag gaagctgccg ctaaggaggc tgccgctaag 120
gaagctgcgg cgaaagct 138
<210> 9
<211> 109
<212> PRT
<213> 大肠杆菌
<400> 9
Met Ser Asp Lys Ile Ile His Leu Thr Asp Asp Ser Phe Asp Thr Asp
1 5 10 15
Val Leu Lys Ala Asp Gly Ala Ile Leu Val Asp Phe Trp Ala Glu Trp
20 25 30
Cys Gly Pro Cys Lys Met Ile Ala Pro Ile Leu Asp Glu Ile Ala Asp
35 40 45
Glu Tyr Gln Gly Lys Leu Thr Val Ala Lys Leu Asn Ile Asp Gln Asn
50 55 60
Pro Gly Thr Ala Pro Lys Tyr Gly Ile Arg Gly Ile Pro Thr Leu Leu
65 70 75 80
Leu Phe Lys Asn Gly Glu Val Ala Ala Thr Lys Val Gly Ala Leu Ser
85 90 95
Lys Gly Gln Leu Lys Glu Phe Leu Asp Ala Asn Leu Ala
100 105
<210> 10
<211> 367
<212> PRT
<213> 大肠杆菌
<400> 10
Met Lys Ile Glu Glu Gly Lys Leu Val Ile Trp Ile Asn Gly Asp Lys
1 5 10 15
Gly Tyr Asn Gly Leu Ala Glu Val Gly Lys Lys Phe Glu Lys Asp Thr
20 25 30
Gly Ile Lys Val Thr Val Glu His Pro Asp Lys Leu Glu Glu Lys Phe
35 40 45
Pro Gln Val Ala Ala Thr Gly Asp Gly Pro Asp Ile Ile Phe Trp Ala
50 55 60
His Asp Arg Phe Gly Gly Tyr Ala Gln Ser Gly Leu Leu Ala Glu Ile
65 70 75 80
Thr Pro Asp Lys Ala Phe Gln Asp Lys Leu Tyr Pro Phe Thr Trp Asp
85 90 95
Ala Val Arg Tyr Asn Gly Lys Leu Ile Ala Tyr Pro Ile Ala Val Glu
100 105 110
Ala Leu Ser Leu Ile Tyr Asn Lys Asp Leu Leu Pro Asn Pro Pro Lys
115 120 125
Thr Trp Glu Glu Ile Pro Ala Leu Asp Lys Glu Leu Lys Ala Lys Gly
130 135 140
Lys Ser Ala Leu Met Phe Asn Leu Gln Glu Pro Tyr Phe Thr Trp Pro
145 150 155 160
Leu Ile Ala Ala Asp Gly Gly Tyr Ala Phe Lys Tyr Glu Asn Gly Lys
165 170 175
Tyr Asp Ile Lys Asp Val Gly Val Asp Asn Ala Gly Ala Lys Ala Gly
180 185 190
Leu Thr Phe Leu Val Asp Leu Ile Lys Asn Lys His Met Asn Ala Asp
195 200 205
Thr Asp Tyr Ser Ile Ala Glu Ala Ala Phe Asn Lys Gly Glu Thr Ala
210 215 220
Met Thr Ile Asn Gly Pro Trp Ala Trp Ser Asn Ile Asp Thr Ser Lys
225 230 235 240
Val Asn Tyr Gly Val Thr Val Leu Pro Thr Phe Lys Gly Gln Pro Ser
245 250 255
Lys Pro Phe Val Gly Val Leu Ser Ala Gly Ile Asn Ala Ala Ser Pro
260 265 270
Asn Lys Glu Leu Ala Lys Glu Phe Leu Glu Asn Tyr Leu Leu Thr Asp
275 280 285
Glu Gly Leu Glu Ala Val Asn Lys Asp Lys Pro Leu Gly Ala Val Ala
290 295 300
Leu Lys Ser Tyr Glu Glu Glu Leu Ala Lys Asp Pro Arg Ile Ala Ala
305 310 315 320
Thr Met Glu Asn Ala Gln Lys Gly Glu Ile Met Pro Asn Ile Pro Gln
325 330 335
Met Ser Ala Phe Trp Tyr Ala Val Arg Thr Ala Val Ile Asn Ala Ala
340 345 350
Ser Gly Arg Gln Thr Val Asp Glu Ala Leu Lys Asp Ala Gln Thr
355 360 365
<210> 11
<211> 225
<212> PRT
<213> Discosoma sp.
<400> 11
Met Ala Ser Ser Glu Asp Val Ile Lys Glu Phe Met Arg Phe Lys Val
1 5 10 15
Arg Met Glu Gly Ser Val Asn Gly His Glu Phe Glu Ile Glu Gly Glu
20 25 30
Gly Glu Gly Arg Pro Tyr Glu Gly Thr Gln Thr Ala Lys Leu Lys Val
35 40 45
Thr Lys Gly Gly Pro Leu Pro Phe Ala Trp Asp Ile Leu Ser Pro Gln
50 55 60
Phe Gln Tyr Gly Ser Lys Val Tyr Val Lys His Pro Ala Asp Ile Pro
65 70 75 80
Asp Tyr Lys Lys Leu Ser Phe Pro Glu Gly Phe Lys Trp Glu Arg Val
85 90 95
Met Asn Phe Glu Asp Gly Gly Val Val Thr Val Thr Gln Asp Ser Ser
100 105 110
Leu Gln Asp Gly Arg Phe Ile Tyr Lys Val Lys Phe Ile Gly Val Asn
115 120 125
Phe Pro Ser Asp Gly Pro Val Met Gln Lys Lys Thr Met Gly Trp Glu
130 135 140
Pro Ser Thr Glu Arg Leu Tyr Pro Arg Asp Gly Val Leu Lys Gly Glu
145 150 155 160
Ile His Lys Ala Leu Lys Leu Lys Asp Gly Gly His Tyr Leu Val Glu
165 170 175
Phe Lys Ser Ile Tyr Met Ala Lys Lys Pro Val Gln Leu Pro Gly Tyr
180 185 190
Tyr Tyr Val Asp Ser Lys Leu Asp Ile Thr Ser His Asn Glu Asp Tyr
195 200 205
Thr Ile Val Glu Gln Tyr Glu Arg Thr Glu Gly Arg His His Leu Phe
210 215 220
Leu
225
<210> 12
<211> 238
<212> PRT
<213> 水母
<400> 12
Met Gly Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val
1 5 10 15
Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly Glu
20 25 30
Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys
35 40 45
Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu
50 55 60
Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Arg
65 70 75 80
His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg
85 90 95
Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val
100 105 110
Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile
115 120 125
Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn
130 135 140
Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly
145 150 155 160
Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val
165 170 175
Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro
180 185 190
Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser
195 200 205
Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val
210 215 220
Thr Ala Ala Gly Ile Thr His Gly Met Asp Glu Leu Tyr Lys
225 230 235
<210> 13
<211> 235
<212> PRT
<213> 珊瑚
<400> 13
Met Arg Lys Gly Glu Glu Asp Asn Met Ala Ile Ile Lys Glu Phe Met
1 5 10 15
Arg Phe Lys Val His Met Glu Gly Ser Val Asn Gly His Glu Phe Glu
20 25 30
Ile Glu Gly Glu Gly Glu Gly Arg Pro Tyr Glu Gly Thr Gln Thr Ala
35 40 45
Lys Leu Lys Val Thr Lys Gly Gly Pro Leu Pro Phe Ala Trp Asp Ile
50 55 60
Leu Ser Pro Gln Phe Met Tyr Gly Ser Lys Ala Tyr Val Lys His Pro
65 70 75 80
Ala Asp Ile Pro Asp Tyr Leu Lys Leu Ser Phe Pro Glu Gly Phe Lys
85 90 95
Trp Glu Arg Val Met Asn Phe Glu Asp Gly Gly Val Val Thr Val Thr
100 105 110
Gln Asp Ser Ser Leu Gln Asp Gly Glu Phe Ile Tyr Lys Val Lys Leu
115 120 125
Arg Gly Thr Asn Phe Pro Ser Asp Gly Pro Val Met Gln Lys Lys Thr
130 135 140
Met Gly Trp Glu Ala Ser Ser Glu Arg Met Tyr Pro Glu Asp Gly Ala
145 150 155 160
Leu Lys Gly Glu Ile Lys Gln Arg Leu Lys Leu Lys Asp Gly Gly His
165 170 175
Tyr Asp Ala Glu Val Lys Thr Thr Tyr Lys Ala Lys Lys Pro Val Gln
180 185 190
Leu Pro Gly Ala Tyr Asn Val Asn Ile Lys Leu Asp Ile Thr Ser His
195 200 205
Asn Glu Asp Tyr Thr Ile Val Glu Gln Tyr Glu Arg Ala Glu Gly Arg
210 215 220
His Ser Thr Gly Gly Met Asp Glu Leu Tyr Lys
225 230 235
<210> 14
<211> 19
<212> DNA
<213> 人工序列
<400> 14
gtcgtggcaa gaataccaa 19
<210> 15
<211> 18
<212> DNA
<213> 人工序列
<400> 15
ggccaggtta ctgccaat 18
<210> 16
<211> 21
<212> DNA
<213> 人工序列
<400> 16
gcgaatttct tatgatttat g 21
<210> 17
<211> 30
<212> DNA
<213> 人工序列
<400> 17
atttttcaat tgaggaaact tgaaaggtgt 30
<210> 18
<211> 25
<212> DNA
<213> 人工序列
<400> 18
tggctttttg attgattgta cagga 25
<210> 19
<211> 25
<212> DNA
<213> 人工序列
<400> 19
tcgcaataat ctatatgctc accaa 25
<210> 20
<211> 23
<212> DNA
<213> 人工序列
<400> 20
tttgcacata aagggtgcct tca 23
<210> 21
<211> 19
<212> DNA
<213> 人工序列
<400> 21
aaagtgccct cggcaaaag 19
<210> 22
<211> 17
<212> DNA
<213> 人工序列
<400> 22
gtacggttta acggagg 17
<210> 23
<211> 29
<212> DNA
<213> 人工序列
<400> 23
aaaccaataa cttataacaa catagcggc 29
<210> 24
<211> 25
<212> DNA
<213> 人工序列
<400> 24
cgacggctat aaaaggaagt tttcc 25
<210> 25
<211> 22
<212> DNA
<213> 人工序列
<400> 25
gaagccaaag cagcaatagc ag 22
<210> 26
<211> 23
<212> DNA
<213> 人工序列
<400> 26
ccttgaagtt ttgaggtgga gta 23
<210> 27
<211> 38
<212> DNA
<213> 人工序列
<400> 27
tccgaaacta ggcagcgtaa acacgagttg tccgatga 38
<210> 28
<211> 41
<212> DNA
<213> 人工序列
<400> 28
cgctgcctag tttcggatca agctgaacat gttagttttg g 41
<210> 29
<211> 25
<212> DNA
<213> 人工序列
<400> 29
ctgctattta ttcattccac cttct 25
<210> 30
<211> 23
<212> DNA
<213> 人工序列
<400> 30
gggaaaatgc ttgatgagtt agg 23
<210> 31
<211> 18
<212> DNA
<213> 人工序列
<400> 31
agtggcggtt gttgtcgt 18
<210> 32
<211> 54
<212> DNA
<213> 人工序列
<400> 32
tcgaataaac acacataaac aaacaaaatg gaaatgactg attttgaact aact 54
<210> 33
<211> 24
<212> DNA
<213> 人工序列
<400> 33
ctggattacg ccaattgtca agat 24
<210> 34
<211> 40
<212> DNA
<213> 人工序列
<400> 34
cttgacaatt ggcgtaatcc agaagcgcag tcaggtttga 40
<210> 35
<211> 21
<212> DNA
<213> 人工序列
<400> 35
gtcttcaacc agtgcgatta t 21
<210> 36
<211> 47
<212> DNA
<213> 人工序列
<400> 36
acgacaacaa ccgccacttt agtcaaaaaa ttagcctttt aattctg 47
<210> 37
<211> 54
<212> DNA
<213> 人工序列
<400> 37
agttagttca aaatcagtca tttccatttt gtttgtttat gtgtgtttat tcga 54
<210> 38
<211> 22
<212> DNA
<213> 人工序列
<400> 38
aaacaacttc aaaagaaccc tc 22
<210> 39
<211> 52
<212> DNA
<213> 人工序列
<400> 39
actaaaccta attctaacaa gcaaagttct tcatttagaa aaatttcagc tg 52
<210> 40
<211> 53
<212> DNA
<213> 人工序列
<400> 40
gctgaaattt ttctaaatga agaactttgc ttgttagaat taggtttagt ttg 53
<210> 41
<211> 16
<212> DNA
<213> 人工序列
<400> 41
taggctgtgc cgacat 16
<210> 42
<211> 19
<212> DNA
<213> 人工序列
<400> 42
aagacgggtc ggatacctg 19
<210> 43
<211> 44
<212> DNA
<213> 人工序列
<400> 43
caatagagca cctggcagtc atctcgacgg gagtggaaag aacg 44
<210> 44
<211> 42
<212> DNA
<213> 人工序列
<400> 44
ctcaggtata gcatgaggtc gctctaagca tcttgccctg tg 42
<210> 45
<211> 19
<212> DNA
<213> 人工序列
<400> 45
ggctagatta ttctcagga 19
<210> 46
<211> 44
<212> DNA
<213> 人工序列
<400> 46
gtttcccgtt ctttccactc ccgtcgagat gactgccagg tgct 44
<210> 47
<211> 46
<212> DNA
<213> 人工序列
<400> 47
gggccaagca cagggcaaga tgcttagagc gacctcatgc tatacc 46
<210> 48
<211> 24
<212> DNA
<213> 人工序列
<400> 48
tgtctgctac attcataata acca 24
<210> 49
<211> 21
<212> DNA
<213> 人工序列
<400> 49
tttgacagtt atacgtagca t 21
<210> 50
<211> 25
<212> DNA
<213> 人工序列
<400> 50
aactttatga tgatttgcga gagta 25
<210> 51
<211> 58
<212> DNA
<213> 人工序列
<400> 51
ccccagtaac ctcaggaacg tgacaactac ttttctttag cttttcttct gttggtga 58
<210> 52
<211> 52
<212> DNA
<213> 人工序列
<400> 52
cgttcctgag gttactgggg acaagggaac actgaaacac cctaaaggaa ag 52
<210> 53
<211> 22
<212> DNA
<213> 人工序列
<400> 53
accttcccct catttttgta cg 22
<210> 54
<211> 23
<212> DNA
<213> 人工序列
<400> 54
gatacagcat gtcctccgct att 23
<210> 55
<211> 55
<212> DNA
<213> 人工序列
<400> 55
tgtcctccaa ttatttgttt cacaaggata atagtacgcc gattcatgag atgct 55
<210> 56
<211> 48
<212> DNA
<213> 人工序列
<400> 56
gtgaaacaaa taattggagg acagtcaata gcggttggga gtgctact 48
<210> 57
<211> 22
<212> DNA
<213> 人工序列
<400> 57
agtttgctgc tgatttggat gc 22
<210> 58
<211> 23
<212> DNA
<213> 人工序列
<400> 58
gatacagcat gtcctccgct att 23
<210> 59
<211> 49
<212> DNA
<213> 人工序列
<400> 59
cttaatatac atgggacgaa aagcggataa tagtacgccg attcatgag 49
<210> 60
<211> 49
<212> DNA
<213> 人工序列
<400> 60
atcgcacaga attcccttgt attataggac agtcaatagc ggttgggag 49
<210> 61
<211> 22
<212> DNA
<213> 人工序列
<400> 61
agtttgctgc tgatttggat gc 22
<210> 62
<211> 46
<212> DNA
<213> 人工序列
<400> 62
catctcatga atcggcgtac tattatccgc ttttcgtccc atgtat 46
<210> 63
<211> 47
<212> DNA
<213> 人工序列
<400> 63
cactcccaac cgctattgac tgtcctataa tacaagggaa ttctgtg 47
<210> 64
<211> 17
<212> DNA
<213> 人工序列
<400> 64
gcattgcccg ccatcag 17
<210> 65
<211> 25
<212> DNA
<213> 人工序列
<400> 65
tttccaaatc atatctctgt tctgc 25
<210> 66
<211> 19
<212> DNA
<213> 人工序列
<400> 66
gtcgtggcaa gaataccaa 19
<210> 67
<211> 18
<212> DNA
<213> 人工序列
<400> 67
ggccaggtta ctgccaat 18
<210> 68
<211> 21
<212> DNA
<213> 人工序列
<400> 68
gcgaatttct tatgatttat g 21
<210> 69
<211> 30
<212> DNA
<213> 人工序列
<400> 69
atttttcaat tgaggaaact tgaaaggtgt 30
<210> 70
<211> 25
<212> DNA
<213> 人工序列
<400> 70
tggctttttg attgattgta cagga 25
<210> 71
<211> 25
<212> DNA
<213> 人工序列
<400> 71
tcgcaataat ctatatgctc accaa 25
<210> 72
<211> 19
<212> DNA
<213> 人工序列
<400> 72
gtcgtggcaa gaataccaa 19
<210> 73
<211> 18
<212> DNA
<213> 人工序列
<400> 73
ggccaggtta ctgccaat 18
<210> 74
<211> 21
<212> DNA
<213> 人工序列
<400> 74
gcgaatttct tatgatttat g 21
<210> 75
<211> 30
<212> DNA
<213> 人工序列
<400> 75
atttttcaat tgaggaaact tgaaaggtgt 30
<210> 76
<211> 25
<212> DNA
<213> 人工序列
<400> 76
tggctttttg attgattgta cagga 25
<210> 77
<211> 25
<212> DNA
<213> 人工序列
<400> 77
tcgcaataat ctatatgctc accaa 25
Claims (13)
1.一种重组酿酒酵母,表达合成大麻萜酚酸途径的酶、能够合成大麻萜酚酸,其特征在于,表达大麻二酚酸合成途径中的大麻二酚酸合成酶,部分内源性基因被过表达或敲除,所述部分内源性基因包括:Fad1、Fmn1、Hac1、Pep4、Prb1、Mrs2、Gal80、Gal4、Erv29、Der1;
所述部分内源性基因被过表达或敲除是(a)~(f)任一种:
(a)同时过表达Fad1、Fmn1、Hac1,敲除Pep4,
(b)在(a)的基础上,敲除Prb1,
(c)过表达Fad1、Fmn1,敲除Pep4、Mrs2、敲除Gal80、过表达Gal4,
(d)过表达Fad1、Fmn1,敲除Pep4、Mrs2、敲除Gal80、过表达Gal4、过表达Erv29,
(e)过表达Fad1、Fmn1、Hac1、Gal4,敲除Pep4、Der1、Gal80,
(f)过表达Fad1、Fmn1、Hac1,敲除Pep4、Gal80、过表达Gal4。
2. 根据权利要求1所述的一种重组酿酒酵母,其特征在于,所述编码大麻二酚酸合成酶的基因的核苷酸序列是SEQ ID NO:1。
3.根据权利要求1或2所述的一种重组酿酒酵母,其特征在于,表达大麻二酚酸合成酶是指将编码基因插入到酿酒酵母基因组上、通过内源性pGal1启动子启动表达。
4.根据权利要求1或2所述的一种重组酿酒酵母,其特征在于,所述大麻二酚酸合成酶通过或不通过linker与标签蛋白进行融合表达。
5.根据权利要求3所述的一种重组酿酒酵母,其特征在于,所述大麻二酚酸合成酶通过或不通过linker与标签蛋白进行融合表达。
6. 根据权利要求4所述的一种重组酿酒酵母,其特征在于,所述linker的序列如SEQID NO:2~ SEQ ID NO:8任一所示。
7. 根据权利要求5所述的一种重组酿酒酵母,其特征在于,所述linker的序列如SEQID NO:2~ SEQ ID NO:8任一所示。
8.根据权利要求4所述的一种重组酿酒酵母,其特征在于,所述标签蛋白是TrxA、MBP、DsRed.T3、GFP或mCherry。
9.根据权利要求5所述的一种重组酿酒酵母,其特征在于,所述标签蛋白是TrxA、MBP、DsRed.T3、GFP或mCherry。
10.构建权利要求1~9任一所述重组酿酒酵母的方法,其特征在于,包括以下步骤:
(1)PCR扩增得到需要过表达的基因的表达盒,整合到酿酒酵母基因组上;或者,PCR扩增得到用于敲除基因的同源片段,用同源片段替换酿酒酵母基因组上的待敲除基因;
使用CRISPR-Cas9技术实现酿酒酵母基因组上的基因敲除和插入;
(2)筛选获得阳性克隆。
11.权利要求1~9任一所述重组酿酒酵母在生产大麻二酚酸中的应用。
12.根据权利要求11所述的应用,其特征在于,包括以下步骤:
(1)活化培养重组酿酒酵母,并培养得到重组酿酒酵母种子液,
(2)将重组酿酒酵母种子液转接到合适产大麻二酚酸的培养基中,在适宜条件下培养重组酿酒酵母使之产大麻二酚酸。
13.权利要求1~9任一所述重组酿酒酵母在生产大麻二酚中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210098008.0A CN114657078B (zh) | 2022-01-27 | 2022-01-27 | 一种高产大麻二酚酸的酿酒酵母菌株构建方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210098008.0A CN114657078B (zh) | 2022-01-27 | 2022-01-27 | 一种高产大麻二酚酸的酿酒酵母菌株构建方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114657078A CN114657078A (zh) | 2022-06-24 |
CN114657078B true CN114657078B (zh) | 2024-04-02 |
Family
ID=82026230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210098008.0A Active CN114657078B (zh) | 2022-01-27 | 2022-01-27 | 一种高产大麻二酚酸的酿酒酵母菌株构建方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114657078B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024098353A1 (zh) * | 2022-11-11 | 2024-05-16 | 中国科学院深圳先进技术研究院 | 一种产大麻萜酚酸的重组酿酒酵母及其构建方法和应用 |
CN116891808B (zh) * | 2023-07-12 | 2024-07-09 | 森瑞斯生物科技(深圳)有限公司 | 一种亚细胞结构定位的大麻二酚酸合成酶的酿酒酵母菌株构建方法和应用 |
CN116904412B (zh) * | 2023-07-25 | 2024-04-26 | 森瑞斯生物科技(深圳)有限公司 | 一种大麻二酚酸合成酶序列优化的酿酒酵母菌株构建方法和应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110484572A (zh) * | 2019-08-30 | 2019-11-22 | 浙江工业大学 | 一种提高酿酒酵母橙花叔醇产量的方法 |
WO2020069214A2 (en) * | 2018-09-26 | 2020-04-02 | Demetrix, Inc. | Optimized expression systems for producing cannabinoid synthase polypeptides, cannabinoids, and cannabinoid derivatives |
CN113416748A (zh) * | 2021-06-11 | 2021-09-21 | 湖北碳元本草生物科技有限公司 | 一种合成大麻二酚的表达载体、异源表达方法及应用 |
CN113528365A (zh) * | 2021-07-13 | 2021-10-22 | 浙江寿仙谷医药股份有限公司 | 产大麻二酚的重组酿酒酵母、其构建方法以及应用 |
WO2021225952A1 (en) * | 2020-05-08 | 2021-11-11 | Lygos, Inc. | Large scale production of olivetol, olivetolic acid and other alkyl resorcinols by fermentation |
WO2023288188A1 (en) * | 2021-07-13 | 2023-01-19 | Amyris, Inc. | High efficency production of cannabigerolic acid and cannabidiolic acid |
CN115927029A (zh) * | 2022-11-11 | 2023-04-07 | 中国科学院深圳先进技术研究院 | 一种产大麻萜酚酸的重组酿酒酵母及其构建方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020236789A1 (en) * | 2019-05-22 | 2020-11-26 | Demetrix, Inc. | Optimized cannabinoid synthase polypeptides |
EP4017972A1 (en) * | 2019-08-19 | 2022-06-29 | Biomedican, Inc. | Production of cannabinoids |
-
2022
- 2022-01-27 CN CN202210098008.0A patent/CN114657078B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020069214A2 (en) * | 2018-09-26 | 2020-04-02 | Demetrix, Inc. | Optimized expression systems for producing cannabinoid synthase polypeptides, cannabinoids, and cannabinoid derivatives |
CN110484572A (zh) * | 2019-08-30 | 2019-11-22 | 浙江工业大学 | 一种提高酿酒酵母橙花叔醇产量的方法 |
WO2021225952A1 (en) * | 2020-05-08 | 2021-11-11 | Lygos, Inc. | Large scale production of olivetol, olivetolic acid and other alkyl resorcinols by fermentation |
CN113416748A (zh) * | 2021-06-11 | 2021-09-21 | 湖北碳元本草生物科技有限公司 | 一种合成大麻二酚的表达载体、异源表达方法及应用 |
CN113528365A (zh) * | 2021-07-13 | 2021-10-22 | 浙江寿仙谷医药股份有限公司 | 产大麻二酚的重组酿酒酵母、其构建方法以及应用 |
WO2023288188A1 (en) * | 2021-07-13 | 2023-01-19 | Amyris, Inc. | High efficency production of cannabigerolic acid and cannabidiolic acid |
CN115927029A (zh) * | 2022-11-11 | 2023-04-07 | 中国科学院深圳先进技术研究院 | 一种产大麻萜酚酸的重组酿酒酵母及其构建方法和应用 |
Non-Patent Citations (3)
Title |
---|
Elucidation of structure-function relationship of THCA and CBDA synthase from Cannabis sativa L.;Bastian Zirpel等;Journal of Biotechnology;第17-26页 * |
HAC1基因过表达对重组人CTLA-4蛋白在毕赤酵母中分泌表达的影响;何秋焱等;复旦学报(自然科学版);20151207;第54卷(第6期);第778-785页 * |
大麻CBDAS基因家族成员的全基因组鉴定及表达分析;潘根等;华北农学报;第36卷(第S1期);第1-7页 * |
Also Published As
Publication number | Publication date |
---|---|
CN114657078A (zh) | 2022-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114657078B (zh) | 一种高产大麻二酚酸的酿酒酵母菌株构建方法和应用 | |
CN109988722B (zh) | 一种重组酿酒酵母菌株及其应用和生产酪醇和/或红景天苷的方法 | |
EA023764B1 (ru) | Генетически модифицированная клетка и способ использования упомянутой клетки | |
CN116286900B (zh) | 一种乙酸渗透酶A基因RkAcpa及其应用 | |
CN111205993A (zh) | 生产熊果酸和齐墩果酸的重组酵母菌及其构建方法和应用 | |
CN115011616B (zh) | 一种乙醛脱氢酶基因rkaldh及其应用 | |
CN115873836B (zh) | 一种橙花叔醇合成酶及应用 | |
CN115927029A (zh) | 一种产大麻萜酚酸的重组酿酒酵母及其构建方法和应用 | |
CN113234610A (zh) | 一种合成角鲨烯的酿酒酵母菌株及其应用 | |
CN111088254B (zh) | 一种内源搭载的外源基因高效可控表达系统 | |
CN113151024A (zh) | 一种发酵合成四氢嘧啶的酿酒酵母工程菌株 | |
CN114672525B (zh) | N-乙酰基-5-甲氧基色胺的生物合成方法及其应用 | |
CN116904412B (zh) | 一种大麻二酚酸合成酶序列优化的酿酒酵母菌株构建方法和应用 | |
CN116891808B (zh) | 一种亚细胞结构定位的大麻二酚酸合成酶的酿酒酵母菌株构建方法和应用 | |
CN112391300B (zh) | 水飞蓟来源的黄酮3β-羟化酶及其辅酶的应用 | |
CN115305254A (zh) | 一种萜类底盘微生物与工程菌及其构建方法和应用 | |
JP7072809B2 (ja) | 組換え微生物、その製造方法及び補酵素q10の生産における使用 | |
CN110100003A (zh) | 迈诺醇的生产 | |
CN117187225A (zh) | 一种橙花叔醇合成酶及应用 | |
CN114717124B (zh) | 一株高产麦角甾醇的酿酒酵母工程菌株、构建方法及应用 | |
CN113416239B (zh) | 一个参与阳春砂乙酸龙脑酯合成调控的转录因子AvbHLH3及其应用 | |
CN112852847B (zh) | 一种重组酿酒酵母菌株及其构建方法与应用 | |
CN114134186A (zh) | 以葡萄糖为底物生物法合成5-羟基β-吲哚基丙氨酸的方法 | |
CN115896211A (zh) | 一种发酵生产胞磷胆碱的基因工程菌及应用 | |
CN109438563B (zh) | 一种烟草kup7蛋白及其编码基因与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |